
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3EAuthor Manuscript%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="18DE209A930A416300209A00C32719AF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="nihpa">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="manuscript">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancer research">
<meta name="citation_title" content="Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma">
<meta name="citation_author" content="Guofei Cui">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Yi Zhou">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Department of Infectious Diseases, Xi&#x27;an Jiaotong University, Xi&#x27;an, China.">
<meta name="citation_author" content="Weiting Liao">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Eleonora Cossu">
<meta name="citation_author_institution" content="Institute of Pathology, University of Regensburg, Regensburg, Germany.">
<meta name="citation_author" content="Matthias Evert">
<meta name="citation_author_institution" content="Institute of Pathology, University of Regensburg, Regensburg, Germany.">
<meta name="citation_author" content="Shu Zhang">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Head and Neck Oncology Department, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.">
<meta name="citation_author" content="Jingxiao Wang">
<meta name="citation_author_institution" content="School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.">
<meta name="citation_author" content="Shanshan Deng">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Andrew Yonemura">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Lucie David">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Meng Xu">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author_institution" content="Department of General Surgery, the Second Affiliated Hospital of Xi&#x27;an Jiaotong University, Xi&#x27;an, China.">
<meta name="citation_author" content="Juliette M Doumergue">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Xinjun Lu">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Department of Biliary-Pancreatic Surgery, Sun Yat-sen University, Guangzhou, China.">
<meta name="citation_author" content="Lihui Yang">
<meta name="citation_author_institution" content="School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.">
<meta name="citation_author" content="Jinghua Li">
<meta name="citation_author_institution" content="School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.">
<meta name="citation_author" content="Binyong Liang">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Hepatic Surgery Center, Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.">
<meta name="citation_author" content="Haichuan Wang">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.">
<meta name="citation_author_institution" content="Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.">
<meta name="citation_author" content="Hongwei Xu">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.">
<meta name="citation_author" content="Sheng Zhong">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author" content="Youping Deng">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Diego F Calvisi">
<meta name="citation_author_institution" content="Institute of Pathology, University of Regensburg, Regensburg, Germany.">
<meta name="citation_author" content="Jinqiu Zhao">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author_institution" content="Department of Infectious Disease, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.">
<meta name="citation_author_institution" content="Western Institute of Digital-Intelligent Medicine, Chongqing 401329, China.">
<meta name="citation_author" content="Xin Chen">
<meta name="citation_author_institution" content="Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_author" content="Xue Wang">
<meta name="citation_author_institution" content="Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.">
<meta name="citation_publication_date" content="2025 Sep 12">
<meta name="citation_firstpage" content="10.1158/0008-5472.CAN-25-1615">
<meta name="citation_doi" content="10.1158/0008-5472.CAN-25-1615">
<meta name="citation_pmid" content="40939191">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/pdf/nihms-2112487.pdf">
<meta name="description" content="Aberrant activation of AKT is a key oncogenic driver in hepatocellular carcinoma (HCC). As AKT activates multiple downstream signaling pathways, the key mechanisms mediating AKT-driven tumorigenesis must be elucidated to develop optimal treatment ...">
<meta name="og:title" content="Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Aberrant activation of AKT is a key oncogenic driver in hepatocellular carcinoma (HCC). As AKT activates multiple downstream signaling pathways, the key mechanisms mediating AKT-driven tumorigenesis must be elucidated to develop optimal treatment ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12500318">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1158/0008-5472.CAN-25-1615"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/nihms-2112487.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12500318%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12500318/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12500318/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nihpa.png" alt="NIHPA Author Manuscripts logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to NIHPA Author Manuscripts" title="Link to NIHPA Author Manuscripts" shape="default" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancer Res</button></div>. Author manuscript; available in PMC: 2025 Oct 7.</div>
<div>
<em>Published before final editing as: </em>Cancer Res. 2025 Sep 12:10.1158/0008-5472.CAN-25-1615. doi: <a href="https://doi.org/10.1158/0008-5472.CAN-25-1615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1158/0008-5472.CAN-25-1615</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cui%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Guofei Cui</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Guofei Cui</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cui%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guofei Cui</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yi Zhou</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yi Zhou</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>3</sup>Department of Infectious Diseases, Xi'an Jiaotong University, Xi'an, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Zhou</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Weiting Liao</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Weiting Liao</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liao%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weiting Liao</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cossu%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Eleonora Cossu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Eleonora Cossu</span></h3>
<div class="p">
<sup>4</sup>Institute of Pathology, University of Regensburg, Regensburg, Germany.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cossu%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eleonora Cossu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evert%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Matthias Evert</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Matthias Evert</span></h3>
<div class="p">
<sup>4</sup>Institute of Pathology, University of Regensburg, Regensburg, Germany.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Evert%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matthias Evert</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shu Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shu Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>5</sup>Head and Neck Oncology Department, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shu Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jingxiao Wang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jingxiao Wang</span></h3>
<div class="p">
<sup>6</sup>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jingxiao Wang</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Shanshan Deng</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Shanshan Deng</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shanshan Deng</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yonemura%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Andrew Yonemura</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Andrew Yonemura</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yonemura%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrew Yonemura</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22David%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Lucie David</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Lucie David</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22David%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucie David</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Meng Xu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Meng Xu</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">
<sup>7</sup>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Meng Xu</span></a>
</div>
</div>
<sup>2,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doumergue%20JM%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Juliette M Doumergue</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Juliette M Doumergue</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doumergue%20JM%22%5BAuthor%5D" class="usa-link"><span class="name western">Juliette M Doumergue</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Xinjun Lu</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Xinjun Lu</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>8</sup>Department of Biliary-Pancreatic Surgery, Sun Yat-sen University, Guangzhou, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinjun Lu</span></a>
</div>
</div>
<sup>1,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Lihui Yang</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Lihui Yang</span></h3>
<div class="p">
<sup>6</sup>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lihui Yang</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Jinghua Li</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Jinghua Li</span></h3>
<div class="p">
<sup>6</sup>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinghua Li</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Binyong Liang</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Binyong Liang</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>9</sup>Hepatic Surgery Center, Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Binyong Liang</span></a>
</div>
</div>
<sup>1,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Haichuan Wang</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Haichuan Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>10</sup>Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.</div>
<div class="p">
<sup>11</sup>Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haichuan Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>10,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Hongwei Xu</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Hongwei Xu</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>10</sup>Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hongwei Xu</span></a>
</div>
</div>
<sup>1,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Sheng Zhong</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Sheng Zhong</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sheng Zhong</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Youping Deng</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Youping Deng</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Youping Deng</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Calvisi%20DF%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Diego F Calvisi</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Diego F Calvisi</span></h3>
<div class="p">
<sup>4</sup>Institute of Pathology, University of Regensburg, Regensburg, Germany.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Calvisi%20DF%22%5BAuthor%5D" class="usa-link"><span class="name western">Diego F Calvisi</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Jinqiu Zhao</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Jinqiu Zhao</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">
<sup>12</sup>Department of Infectious Disease, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</div>
<div class="p">
<sup>13</sup>Western Institute of Digital-Intelligent Medicine, Chongqing 401329, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinqiu Zhao</span></a>
</div>
</div>
<sup>2,</sup><sup>12,</sup><sup>13,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Xin Chen</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Xin Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xin Chen</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Xue Wang</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Xue Wang</span></h3>
<div class="p">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xue Wang</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>1</sup>Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.</div>
<div id="A2">
<sup>2</sup>Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.</div>
<div id="A3">
<sup>3</sup>Department of Infectious Diseases, Xi'an Jiaotong University, Xi'an, China.</div>
<div id="A4">
<sup>4</sup>Institute of Pathology, University of Regensburg, Regensburg, Germany.</div>
<div id="A5">
<sup>5</sup>Head and Neck Oncology Department, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.</div>
<div id="A6">
<sup>6</sup>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.</div>
<div id="A7">
<sup>7</sup>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</div>
<div id="A8">
<sup>8</sup>Department of Biliary-Pancreatic Surgery, Sun Yat-sen University, Guangzhou, China.</div>
<div id="A9">
<sup>9</sup>Hepatic Surgery Center, Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</div>
<div id="A10">
<sup>10</sup>Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.</div>
<div id="A11">
<sup>11</sup>Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.</div>
<div id="A12">
<sup>12</sup>Department of Infectious Disease, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</div>
<div id="A13">
<sup>13</sup>Western Institute of Digital-Intelligent Medicine, Chongqing 401329, China.</div>
<div class="author-notes p">
<div class="fn" id="FN1">
<p id="P1">Authorsâ€™ contributions</p>
<p id="P2">GFC and XC designed the study. XW, XC, JQZ, YPD, and DFC supervised the project. GFC performed experiments, acquired and analyzed the data, and wrote and revised the manuscript. GFC, XW, XC, JQZ, and DFC discussed and edited the manuscript. GFC generated plasmids and mouse models and bred mice. YZ and SZ acquired some pilot data of Foxo1 and TSC2. WTL, XW, JXW, LHY, JHL, and GFC performed RNA sequencing data analysis. DFC and EC obtained human data. GFC, XW, and XC performed human HCC data analysis. GFC, XW, AY, LD, MX, and JD provided the revised data. SZ generated a CRISPR plasmid. SSD, XJL, BYL, HCW, HWX, and JQZ provided technical assistance. XC and ME obtained funding.</p>
</div>
<div class="fn" id="CR1">
<sup>*</sup><p class="display-inline">Corresponding authors: Jinqiu Zhao, Ph.D., Department of Infectious Disease, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. <span>jinqiuzhao@hospital.cqmu.edu.cn</span>., Xin Chen, Ph.D., Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. <span>xin.chen3@hawaii.edu</span>; Xue Wang, Ph.D., Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA. <span>xuewang@hawaii.edu</span>.</p>
</div>
</div>
</div>
<div id="clp_a" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div>PMCID: PMC12500318Â Â NIHMSID: NIHMS2112487Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40939191/" class="usa-link">40939191</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>The publisher's version of this article is available at <a href="https://doi.org/10.1158/0008-5472.CAN-25-1615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Cancer Res</a>
</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ABS1"><h2>Abstract</h2>
<p id="P3">Aberrant activation of AKT is a key oncogenic driver in hepatocellular carcinoma (HCC). As AKT activates multiple downstream signaling pathways, the key mechanisms mediating AKT-driven tumorigenesis must be elucidated to develop optimal treatment strategies. Using an <em>Akt</em>/<em>NRas</em>-induced HCC mouse model, we found that AKT promotes tumorigenesis by targeting TSC2 and GSK3Î±/Î² rather than FOXO family members. Loss of either TSC2, leading to mTORC1 activation, or both GSK3 isoforms cooperated with activated NRAS to promote HCC formation <em>in vivo</em>, albeit with different latencies. Simultaneous TSC2 and GSK3Î±/Î² deletion cooperated with NRAS to rapidly induce HCC formation, mirroring observations from the <em>Akt</em>/<em>NRas</em> HCC model. RNA-seq studies indicated distinct pathways regulated by TSC2/mTORC1 and GSK3Î±/Î² during hepatocarcinogenesis, with FOXM1 functioning as a major effector of GSK3. In summary, these findings uncover AKTâ€™s role in suppressing the TSC complex and GSK3 to drive HCC, offering mechanistic insights into oncogenic signaling and potential therapeutic targets.</p></section><section id="S1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="P4">Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the third leading cause of cancer-related deaths worldwide(<a href="#R1" class="usa-link" aria-describedby="R1">1</a>). The Food and Drug Administration has approved various therapies for advanced HCC(<a href="#R2" class="usa-link" aria-describedby="R2">2</a>), including tyrosine kinase inhibitors like sorafenib(<a href="#R3" class="usa-link" aria-describedby="R3">3</a>,<a href="#R4" class="usa-link" aria-describedby="R4">4</a>) and Lenvatinib(<a href="#R5" class="usa-link" aria-describedby="R5">5</a>), as well as a combination of immunotherapy and anti-angiogenesis therapy, namely atezolizumab and bevacizumab(<a href="#R5" class="usa-link" aria-describedby="R5">5</a>). However, improving overall survival and reducing recurrence in HCC patients remains challenging. Therefore, it is urgent to investigate novel and potentially effective therapeutic targets against this aggressive tumor.</p>
<p id="P5">The PI3K/AKT pathway plays a critical role in HCC development. Multiple genetic events leading to AKT activation have been reported in human HCC. For instance, activated mutations of <em>PIK3CA</em> regulate genes involved in various cellular processes such as proliferation, survival, migration, metabolism, differentiation, and glucose homeostasis(<a href="#R6" class="usa-link" aria-describedby="R6">6</a>â€“<a href="#R8" class="usa-link" aria-describedby="R8">8</a>). In this pathway, phosphorylation at T308 and S473 residues activates the AKT serine/threonine kinase. Once activated, AKT phosphorylates and inhibits some canonical downstream targets, such as forkhead box O protein (Foxo)(<a href="#R9" class="usa-link" aria-describedby="R9">9</a>,<a href="#R10" class="usa-link" aria-describedby="R10">10</a>), tuberous sclerosis complex 2 (TSC2)(<a href="#R11" class="usa-link" aria-describedby="R11">11</a>), and glycogen synthase kinase 3 (GSK3)(<a href="#R12" class="usa-link" aria-describedby="R12">12</a>). These AKT targets have also been implicated in HCC development and progression(<a href="#R7" class="usa-link" aria-describedby="R7">7</a>,<a href="#R13" class="usa-link" aria-describedby="R13">13</a>).</p>
<p id="P6">Foxo family members, especially Foxo1, have been considered the primary targets of AKT in the liver. Indeed, loss of <em>Foxo1</em> has been able to rescue ablation of <em>Akt1/2</em>-induced insulin resistance, liver regeneration defects, and liver tumor development(<a href="#R14" class="usa-link" aria-describedby="R14">14</a>). However, the role(s) of Foxos, especially Foxo1, in mediating AKT's oncogenic potential are unknown.</p>
<p id="P7">Another critical AKT interactor is TSC2. Specifically, it inhibits HCC development by negatively regulating mTORC1(<a href="#R15" class="usa-link" aria-describedby="R15">15</a>), a pivotal downstream target of activated AKT signaling. However, while many studies have demonstrated that activated mTORC1 is necessary for AKT-driven cancer development in many tumor types(<a href="#R16" class="usa-link" aria-describedby="R16">16</a>,<a href="#R17" class="usa-link" aria-describedby="R17">17</a>), including HCC(<a href="#R18" class="usa-link" aria-describedby="R18">18</a>), limited data indicate that mTORC1 activation is sufficient for AKT's ability to induce liver tumor development.</p>
<p id="P8">GSK3 is a serine/threonine kinase consisting of two isoforms, GSK3Î± and GSK3Î², which AKT inhibits GSK3 via phosphorylation of GSK3Î± serine 21 and GSK3Î² serine 9 residues(<a href="#R6" class="usa-link" aria-describedby="R6">6</a>). Most studies suggest that GSK3 functions as a tumor suppressor in hepatocarcinogenesis, as lower GSK3Î² expression or higher levels of phosphorylated GSK3Î²Ser9 characterize HCC lesions compared to normal livers or surrounding non-tumorous tissues(<a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a>). The functional significance of GSK3Î±/Î² in mediating AKT's oncogenic role has not been explored to date.</p>
<p id="P9">Here, using <em>in vitro</em> and <em>in vivo</em> mouse models, we investigated the underlying molecular mechanism by which AKT executes its oncogenic program during hepatocarcinogenesis in the <em>Akt/NRas</em>-induced HCC mouse model (<a href="#R21" class="usa-link" aria-describedby="R21">21</a>) and human HCC.</p></section><section id="S2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="S3"><h3 class="pmc_sec_title">Mouse treatments and hydrodynamic injection</h3>
<p id="P10">Wild-type <em>FVB/N</em> (RRID:MGI:2160001) mice, <em>Tsc2</em><sup><em>flox/flox</em></sup> mice(<a href="#R22" class="usa-link" aria-describedby="R22">22</a>), and <em>Foxo1</em><sup><em>flox/flox</em></sup> mice (<a href="#R22" class="usa-link" aria-describedby="R22">22</a>) were from the Jackson Laboratory (Sacramento, CA). At five to seven weeks of age, mice were subjected to hydrodynamic tail vein injection, as described in our earlier investigations (<a href="#R21" class="usa-link" aria-describedby="R21">21</a>,<a href="#R23" class="usa-link" aria-describedby="R23">23</a>,<a href="#R24" class="usa-link" aria-describedby="R24">24</a>). <a href="#SD20" class="usa-link">Supplementary Table 1</a> shows the dosages of plasmids used for HCC murine models. <a href="#SD21" class="usa-link">Supplementary Table 2</a> provides detailed information on the experimental models. Mouse liver tissues were harvested for H&amp;E staining, immunohistochemistry (IHC), Western blot, and RT-qPCR analyses.</p></section><section id="S4"><h3 class="pmc_sec_title">Constructs and reagents</h3>
<p id="P11">Plasmids used for animal studies, including <em>pT3-EF1a-HA-myr-Akt</em> (RRID:Addgene_179909), <em>pT3-CAGGS-NRasV12</em>, <em>pT3-EF1Î±</em> (RRID:Addgene_180149) , <em>pCMV</em>, <em>pCMV-Cre</em> (RRID:Addgene_123133), and pCMV-sleeping beauty transposase (<em>pCMV-SB</em>) (RRID:Addgene_24551), were used in our previous publications(<a href="#R25" class="usa-link" aria-describedby="R25">25</a>). <em>pT3-EF1Î±-GSK3Î±S21A-Myc</em>, <em>pT3-EF1Î±-GSK3Î²S9A-Myc,</em> and <em>pT3-EF1Î±-HA-Foxo1AAA</em> plasmids were obtained by subcloning correspondingly mutated <em>GSK3Î±-Myc</em>, <em>GSK3Î²-Myc,</em> and <em>HA-Foxo1</em> into empty vector <em>pT3-EF1Î±</em> via the Gateway PCR cloning strategy (Invitrogen, Carlsbad, CA). <em>pX330-sgGSK3Î±</em>, <em>pX330-sgGSK3Î²,</em> and <em>pX330-sgFoxm1</em> plasmids were constructed by subcloning the single guide RNA sequences against mouse <em>GSK3Î±</em> gene (<em>sgGSK3Î±</em>), <em>GSK3Î²</em> gene (<em>sgGSK3Î²</em>), and <em>Foxm1</em> gene (<em>sgFoxm1</em>) into <em>pX330-U6-Chimeric_BB-CBh-hSpCas9</em> (<em>pX330</em>) plasmid (RRID:Addgene_42230), respectively. <em>pX330-sgGSK3Î±/Î²</em> plasmid were obtained by subcloning <em>sgGSK3Î±</em> and <em>sgGSK3Î²</em> together into a single pX330 plasmid. For cell studies, plasmids used in this project, including <em>psPAX2</em> (RRID:Addgene_12260), <em>pMD2.G</em> (RRID:Addgene_12259), and <em>pLenti-EGFP</em> (Addgene_17448) were purchased from Addgene (Cambridge, MA). <em>pLenti-GSK3Î±S21A-Myc</em> and <em>pLenti-GSK3Î²S9A-Myc</em> plasmids were constructed by subcloning correspondingly mutated <em>GSK3Î±-Myc</em> and <em>GSK3Î²-Myc</em> into <em>pLentiCRISPRv2</em> (pLenti) plasmid (RRID:Addgene_98290) via the Gateway PCR cloning strategy. Detailed information about each plasmid is included in <a href="#SD22" class="usa-link">Supplementary Table 3</a>. All plasmids were extracted using the Endotoxin Free Prep Kit (Sigma-Aldrich, St. Louis, MO, USA).</p></section><section id="S5"><h3 class="pmc_sec_title">Cell lines and cell culture</h3>
<p id="P12">The human embryonic kidney cell line HEK-293FT (RRID:CVCL_6911) was purchased from Thermo Fisher Scientific (Cat#<a href="https://www.ncbi.nlm.nih.gov/nuccore/R70007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">R70007</a>), which authenticates cell lines by short tandem repeat (STR) profiling, and was passaged in our laboratory for fewer than 6 months after receipt. The mouse HCC cell lines <em>HCC3â€“4</em> and <em>HCC4â€“4</em> were derived from <em>c-MYC</em> transgenic mice originally established by Dr. Dean W. Felsher at Stanford University and were characterized by DNA profiling (<a href="#R26" class="usa-link" aria-describedby="R26">26</a>,<a href="#R27" class="usa-link" aria-describedby="R27">27</a>). We routinely validated the identity of these cells by confirming the expression of human <em>c-MYC</em> using Western blotting (Cat#18583; RRID:AB_2895543; Cell Signaling Technology). All cells were cultured in Dulbecco's modified Eagle medium (DMEM) (Sigma-Aldrich, St. Louis, MO) with 10% fetal bovine serum (FBS) (Sigma-Aldrich) and 1% penicillin-streptomycin (PS) (Sigma-Aldrich), and incubated at 37Â°C, 5% CO2. Cell lines were routinely tested and confirmed negative for Mycoplasma contamination by PCR (<a href="#R28" class="usa-link" aria-describedby="R28">28</a>). Cells were maintained in logarithmic growth by refreshing the culture medium every 2â€“3 days and were used for experiments within ten passages after recovery from liquid nitrogen.</p></section><section id="S6"><h3 class="pmc_sec_title">Lentivirus packaging, cell transfection</h3>
<p id="P13">Lentivirus packaging and cell transfection have been described in our previous study (<a href="#R24" class="usa-link" aria-describedby="R24">24</a>). Early passaged HEK-293FT cells were cultured in a DMEM medium without PS before producing lentiviral particles and incubated at 37Â°C, 5% CO2. HEK-293FT cells were seeded in a 6-well plate and incubated until cells reached 60â€“70% confluence, followed by co-transfection with plasmids mixture (2.3Î¼g psPAX2 + 0.7Î¼g pMD2.G + 3Î¼g Plenti-Gene) and 7.5Î¼L Lipofectamine 2000 reagents (Cat#11668â€“019, Invitrogen) diluted in 250mL Opti-MEM (GibcoTM, Cat#31985â€“070, ThermoFisher). Lentiviral supernatant was harvested at 24h, 36h, and 48h after transfection and filtered with a 0.45-mm PES filter (Millipore, Bedford, MA). The medium needs to be changed into fresh medium after every harvest. <em>HCC3â€“4</em> and <em>HCC4â€“4</em> cells were infected at the indicated time points with fresh virus supernatant. After that, cells were treated with puromycin-containing media (3Î¼g mL<sup>âˆ’1</sup> for <em>HCC3â€“4</em> and 2Î¼g/mL for <em>HCC4â€“4</em>) to select cells with stable expression of the target gene with the puromycin resistance. Stably selected cells were used for WB.</p></section><section id="S7"><h3 class="pmc_sec_title">Histology, hematoxylin-eosin (H&amp;E), and immunohistochemistry (IHC) for mouse tissues</h3>
<p id="P14">H&amp;E and IHC have been described in our previous study(<a href="#R24" class="usa-link" aria-describedby="R24">24</a>,<a href="#R29" class="usa-link" aria-describedby="R29">29</a>,<a href="#R30" class="usa-link" aria-describedby="R30">30</a>). Fresh liver tissue samples were fixed with 10% Neutral Buffered Formalin (Cat# 5701, ThermoFisher Scientific) at 4Â°C overnight, followed by paraffin-embedding. Paraffin-embedded tissues were cut into sections at a thickness of 5 Î¼m for H&amp;E or IHC staining. For H&amp;E, sections were deparaffinized in xylene, hydrated in alcohols with indicated concentration (100%, 95%, 70%, and 50%), and stained with hematoxylin and eosin (ThermoFisher Scientific) following the standard protocol. For IHC, sections were heated in an oven at 60Â°C overnight, and were deparaffinized in xylene, hydrated in 100%, 95%, 70%, and 50% alcohols, followed by antigen retrieval in Antigen Unmasking Solution (pH 6.0) (Cat#H-3300, Vector Laboratories). Next, the tissue sections were blocked with 10% goat serum and Avidin-Biotin blocking kit (Cat# SP2001, Vector Laboratories, Burlingame, CA) and then incubated with primary antibodies at 4Â°C overnight. The following day, tissue sections were washed in PBS, and endogenous peroxidase was quenched by 3% hydrogen peroxide at room temperature for 10 minutes. Subsequently, slides were incubated with the biotin-conjugated secondary antibody (1:500, Cat# B2770, Thermo Fisher Scientific) for 30 minutes. After washing three times with PBS for 5 minutes each, the immunostaining signals were visualized using the Vectastain Elite ABC Kit (Cat# PK6100, Vector Laboratories, Burlingame, CA) and ImmPACT DAB EqV Peroxidase (HRP) Substrate (Cat# SK4103, Vector Laboratories, Burlingame, CA). Subsequently, sections were immersed in hematoxylin, dehydrated in graded alcohols, and covered-slipped with ClearMount mounting medium (StatLab, Lodi, CA). Antibodies used for IHC are listed in <a href="#SD23" class="usa-link">Supplementary Table 4</a>. Ki67 staining was quantified by calculating the ratio of Ki67â€“positive nuclei to the total number of nuclei within the tumor section using ImageJ software (RRID:SCR_003070; version 1.8.0; National Institutes of Health, USA, <a href="https://imagej.nih.gov/ij/download.html" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://imagej.nih.gov/ij/download.html</a>). Similarly, Ck19 staining was quantified by measuring the Ck19-positive area relative to the total tumor area in the section using the same software.</p></section><section id="S8"><h3 class="pmc_sec_title">Protein extraction and western blot analysis</h3>
<p id="P15">Protein extraction from mouse tissue and Western blotting have been described in our previous study(<a href="#R31" class="usa-link" aria-describedby="R31">31</a>). The homogenized mouse liver tissues and cell pellets were lysed in the M-PER Mammalian Protein Extraction Reagent (Cat# 78501, ThermoFisher Scientific, Waltham, MA, USA) containing the Halt Protease Inhibitor Cocktail (Cat# 1861281, ThermoFisher Scientific, Waltham, MA, USA). The Protein concentration was quantified by the Pierce BCA Protein Assay Kit (Cat# 23225, ThermoFisher Scientific, Waltham, MA, USA). Proteins were then denatured in sample loading buffer (Laemmli Sample buffer: Î²-ME=19:1) and separated by SDS-PAGE, and transferred onto nitrocellulose membranes (Cat# 1704271, Bio-Rad Laboratories, Hercules, CA, USA). Membranes were blocked with 10% (w/v) non-fat milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 hour at room temperature and then incubated with specific primary antibodies at 4Â°C overnight. After washing in TBST for 10 minutes three times, the membranes were incubated with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature. After washing with TBST, membranes were developed with the Clarity Western ECL Substrate (Cat# 1705061 Bio-Rad Laboratories). Antibodies used for WB are listed in <a href="#SD24" class="usa-link">Supplementary Table 5</a>.</p></section><section id="S9"><h3 class="pmc_sec_title">RNA extraction, RNA sequencing analysis</h3>
<p id="P16">Total RNA was extracted from frozen mouse liver specimens using the Quick-RNA<sup>â„¢</sup> Miniprep Kit (Cat# R1055, Zymo Research, Irvine, CA, USA). The detailed information on RNA samples is referred to in <a href="#SD25" class="usa-link">Supplementary Table 6</a>. RNA sample quality was detected using Bioanalyzer (Agilent, Santa Clara, CA). RNA integrity number (RIN) values above 6.8 are required for RNA Sequencing. RNA samples that met the standard were submitted for RNA sequencing. Library preparation and sequencing were performed by Novogene (Sacramento, CA). Raw data (raw reads) of fastq format were first processed through in-house Perl scripts (Novogene). In this step, clean data (clean reads) were obtained by removing reads containing adapters, reads containing poly-N, and low-quality reads from the raw data. At the same time, Q20, Q30, and GC content of the clean data were calculated. All the downstream analyses were based on clean data of high quality. Paired-end reads were mapped to the mouse reference genome (mm10) by Hisat2 v2.0.5. FeatureCounts v1.5.0-p3 was used to count the reads mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and the read count mapped to this gene. Genes' Ensembl IDs were converted to Entrez ID by the Bioconductor Package org.Mm.eg.db (RRID:SCR_006442). Differential expression analysis was performed using the DESeq2 R package (version 1.24.0) (RRID:SCR_015687). The analyzed RNAseq data was shown in <a href="#SD26" class="usa-link">Datasheet S1</a>.</p></section><section id="S10"><h3 class="pmc_sec_title">Histology and immunohistochemistry for human tissue samples</h3>
<p id="P17">Human liver specimens were harvested and fixed in 10% formalin overnight at 4 Â°C and embedded in paraffin. Hematoxylin and eosin (Thermo Fisher Scientific, Waltham, MA, USA) staining was conducted using a standard protocol. For immunohistochemistry, antigen retrieval was achieved by boiling the slides in 10 mM sodium citrate buffer (pH 6.0), then cooling down at room temperature for 30 min. After blocking with 5% goat serum and the Avidin-Biotin blocking kit (Vector Laboratories, Burlingame, CA, USA), the slides were incubated with the anti-p-Akt (Ser473; dilution 1:100; # 4060; RRID:AB_2315049; Cell Signaling Technology, Danvers, MA), anti-p-GSK3Î± (Ser21; dilution 1:100; # 9316; RRID:AB_659836; Cell Signaling Technology), and anti-p-GSK3Î² (Ser9; dilution 1:100; # 9323; RRID:AB_2115201; Cell Signaling Technology) primary antibodies overnight at 4 Â°C. Subsequently, slides were subjected to 3% hydrogen peroxide for 10 min to quench endogenous peroxidase activity, and the biotin-conjugated secondary antibody was applied at a 1:500 dilution for 30 min at room temperature. The reaction was visualized with the Vectastain ABC-Elite Peroxidase Kit (Vector Laboratories, # PK-6100) with ImmPACT DAB (Vector Laboratories, SK-4105) as the chromogen. Finally, slides were counterstained with Mayerâ€™s hematoxylin. Positiveness for p-Akt<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> was assigned to a tumor sample when the immunoreactivity was more intense than in the corresponding non-tumorous surrounding tissue.</p></section><section id="S11"><h3 class="pmc_sec_title">Statistics</h3>
<p id="P18">Data were analyzed using the Prism 9.0 software (RRID:SCR_002798; ImageJGraphPad, San Diego, CA). Comparisons between the two groups were performed using the two-tailed unpaired Studentâ€™s t-test. Comparisons between the multiple groups were performed using the one-way ANOVA test. Survival curves were analyzed using the Log-rank (Mantel-Cox) test. Data are presented as mean Â±SD. P &lt; 0.05 was considered statistically significant.</p></section><section id="S12"><h3 class="pmc_sec_title">Study approval</h3>
<p id="P19">Animal studies were approved by the UCSF or University of Hawaii Cancer Center Animal Care and Use Committee (IACUC) and performed in specific pathogen-free facilities according to the NIH Principles of Laboratory Animal Care rules. Human HCC and corresponding surrounding non-tumorous liver tissues (n=108 for each group) were collected at the University of Regensburg (Regensburg, Germany). The local Ethical Committee of the Medical University of Regensburg (approval code: 17â€“1015-101) provided the Institutional Review Board approval, in compliance with the Helsinki Declaration. Written informed consent was obtained from all individuals.</p></section><section id="S13"><h3 class="pmc_sec_title">Data availability</h3>
<p id="P20">All other raw data generated in this study are available upon request from the corresponding author. The RNA-seq data for this study were deposited in the Gene Expression Omnibus (GEO) database (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301912" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE301912</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301906" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE301906</a>). The analyzed data in <a href="#F6" class="usa-link">Fig. 6A</a> and <a href="#F6" class="usa-link">6B</a> were obtained from the TCGA database via the UALCAN portal [<a href="https://ualcan.path.uab.edu/cgibin/TCGAExResultNew2.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgibin/TCGAExResultNew2.pl?genenam=FOXM1&amp;ctype=LIHC</a>;<a href="https://ualcan.path.uab.edu/cgi-bin/TCGA-survival1.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgi-bin/TCGA-survival1.pl?genenam=FOXM1&amp;ctype=LIHC</a>]. The analyzed data in <a href="#SD10" class="usa-link">Supplementary Fig. S10</a> were obtained from the TCGA database [<a href="https://www.cbioportal.org/results/download?cancer_study_list=lihc_tcga_pan_can_atlas_2018&amp;Z_SCORE_THRESHOLD=2.0&amp;RPPA_SCORE_THRESHOLD=2.0&amp;profileFilter=mutations%2Cstructural_variants%2Cgistic&amp;case_set_id=lihc_tcga_pan_can_atlas_2018_cnaseq&amp;gene_list=FOXM1&amp;geneset_list=&amp;tab_index=tab_visualize&amp;Action=Submit" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cbioportal.org/results/download?cancer_study_list=lihc_tcga_pan_can_atlas_2018&amp;Z_SCORE_THRESHOLD=2.0&amp;RPPA_SCORE_THRESHOLD=2.0&amp;profileFilter=mutations%2Cstructural_variants%2Cgistic&amp;case_set_id=lihc_tcga_pan_can_atlas_2018_cnaseq&amp;gene_list=FOXM1&amp;geneset_list=%20&amp;tab_index=tab_visualize&amp;Action=Submit</a> ]. The analyzed data in <a href="#SD11" class="usa-link">Supplementary Fig. S11</a> were extracted from UALCAN [<a href="https://ualcan.path.uab.edu/cgi-bin/ualcan-depmap-res.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgi-bin/ualcan-depmap-res.pl?genenam=FOXM1&amp;ctype=LIHC</a>]. The analyzed data in <a href="#F8" class="usa-link">Fig. 8E</a> and <a href="#SD16" class="usa-link">Supplementary Fig. S16</a>â€“<a href="#SD18" class="usa-link">18</a> were obtained from the Cancer Proteome Atlas (TCPA) database [<a href="https://tcpa.drbioright.org/rppa500/correlation_analysis.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tcpa.drbioright.org/rppa500/correlation_analysis.html</a>].</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Figure 6. FOXM1 is a target regulated downstream of AKT/GSK3Î±/Î² cascade in HCC.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/88a5f200ba73/nihms-2112487-f0006.jpg" loading="lazy" height="2100" width="1521" alt="Figure 6."></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P57"><strong>A,</strong> The expression level of <em>FOXM1</em> in human HCC samples from TCGA. Normal: n=50; Primary tumor: n=371. <strong>B,</strong> The effect of <em>FOXM1</em> expression level on LIHC patient survival. <strong>C,</strong> RNA-seq analysis of the expression level of <em>Foxm1</em> in normal liver and liver tumor tissues of <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>, <em>sgGSK3Î±/Î²/NRas</em> and <em>Akt/NRas</em>. n=4 per group. Statistical significance was determined by one-way ANOVA test. <strong>D,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>sgGFP</em> or <em>sgFoxm1</em> plasmid together with <em>Akt</em> and <em>NRas</em> plasmids. <strong>E,</strong> The survival curves of <em>Akt/NRas/sgGFP</em> (n=6) and <em>Akt/NRas/sgFoxm1</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>F,</strong> Representative gross images from <em>Akt/NRas/sgGFP</em> (7.6w.p.i.) and <em>Akt/NRas/sgFoxm1</em> (7.6w.p.i.) mice. 6 biological replicates were performed with similar results. <strong>G,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>sgGFP</em> or <em>sgFoxm1</em> plasmid together with <em>sgGSK3Î±/Î²</em> and <em>NRas</em> plasmids. <strong>H,</strong> The survival curves of <em>sgGSK3Î±/Î²/NRas/sgGFP</em> (n=6) and <em>sgGSK3Î±/Î²/NRas/sgFoxm1</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>I,</strong> Representative gross images from <em>sgGSK3Î±/Î²/NRas/sgGFP</em> (14.1w.p.i.) mice (n=5) and <em>sgGSK3Î±/Î²/NRas/sgFoxm1</em> (14.1w.p.i. &amp; 24w.p.i.) mice (n=6). Data are presented as mean Â± SD; ** indicates p &lt; 0.01. Abbreviations: w.p.i., weeks post-injection.</p></figcaption></figure><figure class="fig xbox font-sm" id="F8"><h4 class="obj_head">Figure 8. Activated AKT is associated with the inactivation of GSK3Î±/Î² in human HCC patients.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/697295a26296/nihms-2112487-f0008.jpg" loading="lazy" height="2100" width="1523" alt="Figure 8."></p>
<div class="p text-right font-secondary"><a href="figure/F8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P59"><strong>A,</strong> Activation or inhibition status of AKT, GSK3Î±, and GSK3Î² in human HCCs (n=108) as determined by IHC staining. <strong>B,</strong> Correlation between p-AKT<sup>Ser473</sup> and p-GSK3Î±<sup>Ser21</sup>/p-GSK3Î²<sup>Ser9</sup> in human HCC samples in (<strong>A</strong>). <strong>C,</strong> Representative immunohistochemistry patterns of p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins in human hepatocellular carcinoma (HCC; n=108). The upper panels show a non-tumorous surrounding liver tissue (ST) displaying weak or absent immunoreactivity for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> in non-neoplastic hepatocytes. In the middle panels, a human HCC (denominated HCC1) exhibits strong and concomitant enhanced immunoreactivity for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins. The lowest panels depict a second tumor (HCC2), characterized by robust immunolabeling for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins. Abbreviation: H&amp;E, hematoxylin and eosin staining. Original magnifications: 200Ã— in all panels. Scale bar: 100 Î¼m in all panels. <strong>D,</strong> Comparison of p-GSK3Î±<sup>Ser21</sup> and p-GSK3Î²<sup>Ser9</sup> positive (both or either) and both negative immunoreactivity frequency between p-AKT<sup>Ser473</sup>-positive (n=43) and p-AKT<sup>Ser473</sup>-negative (n=65) human HCC samples in (<strong>A</strong>). <strong>E,</strong> The correlation analysis between p-GSK3Î²<sup>Ser9</sup> and FOXM1 in human HCC samples (n=184) from the Cancer Proteome Atlas (TCPA) database.</p></figcaption></figure></section></section><section id="S14"><h2 class="pmc_sec_title">Results</h2>
<section id="S15"><h3 class="pmc_sec_title">Role of Foxo family members in <em>Akt/NRas</em>-induced mouse hepatocarcinogenesis</h3>
<p id="P21"><em>Akt/NRas</em> is an established mouse model to investigate the role of downstream targets of AKT during liver tumor development(<a href="#R21" class="usa-link" aria-describedby="R21">21</a>). Foxo proteins are canonical AKT substrates, and Foxo1 is considered the central Foxo family member in liver biology(<a href="#R32" class="usa-link" aria-describedby="R32">32</a>). Consistently, we observed increased phosphorylation/inactivation of Foxo1 at serine 256 (p-Foxo1<sup>Ser256</sup>) and downregulated Foxo downstream genes in liver tumors of <em>Akt/NRas</em> mice compared to normal livers (<a href="#F1" class="usa-link">Fig. 1A</a>; <a href="#SD1" class="usa-link">Supplementary Fig. S1A</a>), implying that AKT suppresses Foxo1 activity during <em>Akt/NRas</em>-induced hepatocarcinogenesis. Thus, we hypothesized that Foxo1 is the major downstream effector during AKT-driven HCC formation. Therefore, loss of the <em>Foxo1</em> gene combined with activated NRas should recapitulate hepatocarcinogenesis induced by <em>Akt/NRas</em>. To test this hypothesis, we injected two plasmids into <em>Foxo1</em><sup><em>flox/flox</em></sup> mice by hydrodynamic tail vein injection. One plasmid carried the Cre recombinase driven by the cytomegalovirus promoter (pCMV-Cre) to knock out the <em>Foxo1</em> gene, while the other construct contained the activated <em>NRas</em> gene (<em>NrasV12</em>). This strategy allowed the expression of NRas in <em>Foxo1</em> KO hepatocytes (<em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>). The plasmids carrying the activated form of <em>Akt</em> and <em>NRas</em> genes were co-injected as a control (<em>Akt/NRas</em>) (<a href="#F1" class="usa-link">Fig. 1B</a>). Survival curve analysis showed that <em>Akt/NRas</em> mice exhibited a rapid onset of lethal tumor burden at 4â€“6 weeks after injection, in agreement with our previous study(<a href="#R21" class="usa-link" aria-describedby="R21">21</a>). However, <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice did not show signs of tumor development and remained healthy even when harvested at ~22 weeks post-injection (<a href="#F1" class="usa-link">Fig. 1C</a> and <a href="#F1" class="usa-link">D</a>). Upon dissection, <em>Akt/NRas</em> mice exhibited numerous large tumor nodules occupying most of the liver parenchyma by 5 weeks post-injection. In contrast, no tumor nodules could be appreciated on most of <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice; and only a few <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice demonstrated small tumor nodules on the liver at 22 weeks post-injection (<a href="#F1" class="usa-link">Fig. 1E</a>; <a href="#SD21" class="usa-link">Supplementary Table 2</a>). Immunohistochemical analysis showed few and small liver tumor lesions that were negative for Foxo1 expression and positive for p-ERK1/2 expression, consistent with the fact that these tumors were derived from <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> hepatocytes. However, cell proliferation rate (as assessed by Ki67+ staining) was significantly lower than that from <em>Akt/NRas</em> liver tumors (<a href="#F1" class="usa-link">Fig. 1E</a>). These findings imply that <em>Foxo1</em> knockout, associated with NRas activation, does not replicate <em>Akt/NRas</em> hepatocarcinogenesis. This suggests that Foxo1 inhibition is not the primary oncogenic signal during AKT-driven liver tumor formation.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Foxo1 is not a downstream effector of AKT signaling in <em>Akt/NRas</em>-driven hepatocarcinogenesis.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/92898b42033d/nihms-2112487-f0001.jpg" loading="lazy" height="2100" width="1501" alt="Figure 1."></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P52"><strong>A,</strong> Western blot analysis of the levels of p-Foxo1<sup>Ser256</sup>, Foxo1, p-AKT<sup>Ser473</sup>, AKT, ERK1/2 and p-Erk1/2 proteins in normal liver (NL) and liver tumor tissue of <em>Akt/NRas</em> mice. (n=3, per group) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the loading control. <strong>B,</strong> Study design. <em>Foxo1</em><sup><em>flox/flox</em></sup> mice were hydrodynamically injected with either <em>Akt/NRas</em> plasmids (<em>Akt/NRas</em>) or <em>pCMV-Cre/NRas</em> (<em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>) plasmids. <strong>C,</strong> The survival curves of <em>Akt/NRas</em> mice (n=6) and <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice (n=6). Statistical significance was determined by log-rank tests. <strong>D,</strong> Comparisons of liver weight in (<strong>C</strong>) (<em>Akt/NRas</em> n=6; <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> n=9). Statistical significance was determined by the two-tailed unpaired Studentâ€™s t-test. <strong>E,</strong> Representative gross images, H&amp;E, and immunohistochemistry for p-Erk1/2, Foxo1, and Ki67 of liver sections from <em>Akt/NRas</em> and <em>Foxo1</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice. 6 biological replicates were performed with similar results. <strong>F,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>pT3</em> empty vector or <em>pT3-FoxoAAA</em> together with <em>Akt</em> and <em>NRas</em> plasmids. <strong>G,</strong> The survival curves of <em>Akt/NRas/pT3</em> mice (n=6) and <em>Akt/NRas/pT3-FoxoAAA</em> mice (n=6). Statistical significance was determined by log-rank tests. <strong>H,</strong> Representative gross images, H&amp;E, and immunohistochemistry for Myc-tag, and Ki67 of liver sections from <em>Akt/NRas</em> and <em>Akt/NRas/pT3-FoxoAAA</em> mice. 3 biological replicates were performed with similar results. Scale bar: 500 Î¼m (40X), 100 Î¼m (200X) and 50 Î¼m (400X). Data are presented as mean Â± SD; ** indicates p &lt; 0.01, *** indicates p &lt; 0.001; ns (not significant) indicates p&gt;0.05. Abbreviations: H&amp;E, hematoxylin and eosin staining; w.p.i., weeks post-injection.</p></figcaption></figure><p id="P22">As there are multiple Foxo family members, we repeated the experiments with a dominant negative form of Foxo (dnFoxo), which inhibits all Foxo members(<a href="#R33" class="usa-link" aria-describedby="R33">33</a>). Consistently, co-expression of dnFoxo and NRas did not trigger liver tumor formation in mice (<a href="#SD1" class="usa-link">Supplementary Fig. S1B</a> and <a href="#SD1" class="usa-link">S1C</a>).</p>
<p id="P23">Previous studies have shown that AKT-mediated phosphorylation of Foxo1 at T24, S256, and S319 residues causes Foxo1 translocation from the nucleus to the cytoplasm and attenuates its transcriptional activity(<a href="#R6" class="usa-link" aria-describedby="R6">6</a>,<a href="#R9" class="usa-link" aria-describedby="R9">9</a>). To investigate the role of AKT-mediated Foxo1 phosphorylation in HCC, we generated a plasmid carrying the mutant <em>Foxo1</em> gene where all three phosphorylation sites (T24, S256, and S319) of Foxo1 were replaced with alanine (<em>Foxo1AAA</em>), rendering it unable to be phosphorylated by AKT and a constitutively activated Foxo1. Next, the <em>Foxo1AAA</em> construct (<em>pT3-Foxo1AAA</em>) was co-injected with <em>Akt</em> and <em>NRas</em> plasmids into the wild-type mice (<em>Akt/NRas/Foxo1AAA</em>) (<a href="#F1" class="usa-link">Fig. 1F</a>). Additional mice were injected with <em>Akt</em>, <em>NRas</em>, and <em>pT3-EF1Î±</em> empty vector as the control (<em>Akt/NRas/pT3</em>). Notably, overexpression of Foxo1AAA did not inhibit <em>Akt/NRas</em>-driven hepatocarcinogenesis. All mice developed large tumors and were required to be euthanized by 7 to 8 weeks post-injection (<a href="#F1" class="usa-link">Fig. 1G</a>). No significant differences in tumor size (<a href="#F1" class="usa-link">Fig. 1H</a>) and liver weight (<a href="#SD1" class="usa-link">Supplementary Fig. S1D</a>) between the <em>Akt/NRas/Foxo1AAA</em> and control <em>Akt/NRas/pT3</em> groups were detected at this time point. Histological evaluation revealed that overexpression of Foxo1AAA did not affect the liver tumor phenotype of <em>Akt/NRas</em> mice (<a href="#F1" class="usa-link">Fig. 1H</a>), and tumor cells from both cohorts of mice were highly proliferative. These results demonstrate that constitutively activated Foxo1 is unable to inhibit <em>Akt/NRas</em>-induced HCC.</p>
<p id="P24">In summary, the findings indicate that Foxo transcription factors are not the key downstream targets of AKT during <em>Akt/NRas</em>-induced hepatocarcinogenesis.</p></section><section id="S16"><h3 class="pmc_sec_title">TSC/mTORC1 pathway during <em>Akt/NRas</em>-induced hepatocarcinogenesis</h3>
<p id="P25">AKT inhibits TSC2 activity via direct phosphorylation, implying TSC2 as an AKT substrate(<a href="#R6" class="usa-link" aria-describedby="R6">6</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>). TSC/mTORC1 has been considered the major signaling in AKT-driven tumor formation. This notion was substantiated by the fact that loss of mTORC1 by Raptor ablation strongly inhibits <em>Akt/NRas</em>-dependent hepatocarcinogenesis(<a href="#R34" class="usa-link" aria-describedby="R34">34</a>). However, the question remains whether the activation of mTORC1 alone is sufficient to replicate activated AKT and synergizes with NRas to promote liver tumor development. To address this question, we employed the conditional <em>Tsc2</em> KO mice (<em>Tsc2</em><sup><em>flox/flox</em></sup> mice). Thus, we injected the <em>pCMV-Cre</em> plasmid to delete the <em>Tsc2</em> gene, together with the NRas plasmid, into <em>Tsc2</em><sup><em>flox/flox</em></sup> mice (<em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>). Additional <em>Tsc2</em><sup><em>flox/flox</em></sup> mice were injected with <em>Akt/NRas</em> plasmid as the control (<em>Akt/NRas</em>) (<a href="#F2" class="usa-link">Fig. 2A</a>). Survival curve analysis revealed that lethal tumor burden was observed in <em>Akt/NRas</em> mice within 4~6 weeks after injection (<a href="#F2" class="usa-link">Fig. 2B</a>), similar to our previous study(<a href="#R21" class="usa-link" aria-describedby="R21">21</a>). In contrast, large tumor burden occurred in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice only after 18 weeks post-injection (<a href="#F2" class="usa-link">Fig. 2B</a> and <a href="#F2" class="usa-link">C</a>). Consistent with this observation, liver weight in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice prior to 20 weeks post-injection was lower than in <em>Akt/NRas</em> (<em>Tsc2</em><sup><em>+/+</em></sup> genetic background<em>)</em> mice (<a href="#F2" class="usa-link">Fig. 2D</a>). At the late stage (more than 20 weeks post-injection) of tumor development, liver weight in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice increased to levels comparable to those in <em>Akt/NRas</em> mice (<a href="#F2" class="usa-link">Fig. 2D</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Role of TSC2/mTORC1 pathway during <em>Akt/NRas</em>-induced hepatocarcinogenesis.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/fd302b205689/nihms-2112487-f0002.jpg" loading="lazy" height="2100" width="1474" alt="Figure 2."></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P53"><strong>A,</strong> Study design. <em>Tsc2</em><sup><em>flox/flox</em></sup> mice were hydrodynamically injected with either <em>Akt/NRas</em> (<em>Akt/NRas</em>) or <em>pCMV-Cre/NRas</em> (<em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>) plasmids. <strong>B,</strong> The survival curves of <em>Akt/NRas</em> mice (n=6) and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice (n=7). Statistical significance was determined by log-rank tests. <strong>C,</strong> Representative gross images, H&amp;E, and IHC for Ki67 and Ck19 of liver sections from <em>Akt/NRas</em> mice and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> mice. Tumor area was labeled as â€œTâ€. Scale bar: 200 Î¼m (100X), 100 Î¼m (200X), and 50 Î¼m (400X). <strong>D,</strong> Liver weights were compared among <em>Akt/NRas</em> mice (4â€“7 weeks post-injection, n = 6), early-stage <em>Tsc2</em><sup><em>â»/â»</em></sup><em>/NRas</em> mice (less than 20 weeks post-injection, n = 4), and late-stage <em>Tsc2</em><sup><em>â»/â»</em></sup><em>/NRas</em> mice (more than 20 weeks post-injection, n = 5). <strong>E,</strong> Quantification of the Ck19 in (<strong>C</strong>). n=18 per group. <strong>F,</strong> Quantification of the Ki67 positive staining in (<strong>C</strong>). n=18 per group. <strong>G,</strong> Western blot analyzing the expression levels of TSC2, p-AKT<sup>Ser473</sup>, AKT, p-p70S6K, p70S6K, p-RPS6, RPS6, p-4EBP1, and 4EBP1 in liver tissues of NL (n=2), <em>Akt/NRas</em> (n=4) or <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> (n=4) mice. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or Î²-Actin was used as the loading control. Statistical significance was determined by the two-tailed unpaired Studentâ€™s t-test in (<strong>D</strong> and <strong>F</strong>). Data are presented as mean Â± SD; * indicates p &lt; 0.05, *** indicates p &lt; 0.001, **** indicates p &lt; 0.0001. Abbreviations: H&amp;E, hematoxylin and eosin staining; NT, surrounding non-tumor sections; T, tumor sections; w.p.i., weeks post-injection.</p></figcaption></figure><p id="P26">Histological evaluation revealed that <em>Akt/NRas</em> liver lesions consisted of highly malignant HCC cells, with some regions exhibiting cholangiocarcinoma (CCA)-like features (as assessed by Ck19+ staining). In contrast, <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> tumors consisted almost exclusively of well or moderately differentiated HCC lesions, and only rarely CCA-like tumors developed (<a href="#F2" class="usa-link">Fig. 2C</a> and <a href="#F2" class="usa-link">E</a>). Tumor cell proliferation rate was also lower in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> than in <em>Akt/NRas</em> lesions (<a href="#F2" class="usa-link">Fig. 2C</a> and <a href="#F2" class="usa-link">F</a>). Previous studies have shown that AKT mediates the inhibition of TSC activity, leading to mTORC1 pathway activation (<a href="#R6" class="usa-link" aria-describedby="R6">6</a>,<a href="#R35" class="usa-link" aria-describedby="R35">35</a>). Thus, we analyzed AKT and mTORC1 activation status in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> and <em>Tsc2</em><sup><em>+/+</em></sup><em>/Akt/NRas</em> HCC lesions using Western blotting (<a href="#F2" class="usa-link">Fig. 2G</a>). As expected, mTORC1 was activated, which could be viewed as high expression of p-p70S6K, p-RPS6, and p-4EBP1, in both <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> and <em>Akt/NRas</em> tumors, whereas a strong AKT activation occurred only in <em>Akt/NRas</em> HCC (<a href="#F2" class="usa-link">Fig. 2G</a>).</p>
<p id="P27">Overall, we discovered that the loss of <em>Tsc2</em>, which leads to the activation of mTORC1, works in conjunction with NRas to induce HCC formation <em>in vivo</em>. However, HCC development occurs over a significantly longer period, and the tumors were less aggressive compared to those found in <em>Akt/NRas</em> mice. These findings suggest that the activation of mTORC1 alone is not sufficient to fully replicate the oncogenic potential of activated AKT during the formation of HCC; additional signals are necessary for this process.</p></section><section id="S17"><h3 class="pmc_sec_title">GSK3Î± and GSK3Î² are the critical AKT downstream targets in hepatocarcinogenesis.</h3>
<p id="P28">The relatively restricted impact of Foxo family members and TSC2/mTORC1 pathway in mediating AKT oncogenic activities indicated that additional pathways might be the major signaling event downstream of activated AKT. Since AKT inhibits the activity of GSK3, which has two isoforms â€”GSK3Î± and GSK3Î²â€” phosphorylated at serine 21 and serine 9 residues by AKT, respectively, we hypothesized that deleting either GSK3Î± and/or GSK3Î² could recapitulate the development of HCC observed in the <em>Akt/NRas</em> mice. In support of our hypothesis, we observed increased levels of p-GSK3Î±<sup>Ser21</sup> and p-GSK3Î²<sup>Ser9</sup> in the tumor lesions of <em>Akt/NRas</em> mice (<a href="#F3" class="usa-link">Fig. 3A</a>). Next, we identified single guide RNA (sgRNA) sequences against mouse <em>GSK3Î±</em> or <em>GSK3Î²</em> gene to effectively inhibit GSK3Î± and GSK3Î² expression <em>in vitro</em> (<a href="#SD2" class="usa-link">Supplementary Fig. S2A</a> and <a href="#SD2" class="usa-link">S2B</a>). As GSK3Î± and GSK3Î² might have redundant roles, we simultaneously knocked out <em>GSK3Î±</em> and <em>GSK3Î²</em> genes using a single CRISPR plasmid carrying sgRNA sequences targeting both <em>GSK3Î±</em> and <em>GSK3Î²</em> (<em>sgGSK3Î±/Î²</em>) (<a href="#SD2" class="usa-link">Supplementary Fig. S2C</a>) and co-injected it with <em>NRas</em> plasmid into <em>FVB/N</em> mice (<em>sgGSK3Î±/Î²/NRas</em>). Either of CRISPR plasmid carrying sgRNA sequence against <em>GFP</em> gene or <em>Akt</em> plasmid together with <em>NRas</em> plasmid were co-injected as the control (<em>sgGFP/NRas</em> and <em>Akt/NRas</em>, respectively) (<a href="#F3" class="usa-link">Fig. 3B</a>). Consistent with our previous studies, <em>Akt/NRas</em> co-expression caused lethal tumor burden within 6 weeks post-injection, whereas activation of NRas alone (as seen in <em>sgGFP/NRas</em> mice) did not induce liver tumor formation (<a href="#F3" class="usa-link">Fig. 3C</a>). Interestingly, the <em>sgGSK3Î±/Î²/NRas</em> mice became moribund due to a lethal tumor burden by approximately 10 weeks post-injection, which was only moderately slower than those injected with <em>Akt</em> and <em>NRas</em> oncogenes (<a href="#F3" class="usa-link">Fig. 3C</a>). Western blotting and IHC confirmed that <em>sgGSK3Î±/Î²/NRas</em> liver tumors expressed GSK3Î± and GSK3Î² at very low level (<a href="#F3" class="usa-link">Fig. 3D</a> and <a href="#F3" class="usa-link">E</a>). Histologically, <em>sgGSK3Î±/Î²/NRas</em> livers were occupied by HCC and CCA-like lesions, similar to those developing in <em>Akt/NRas</em> livers (<a href="#F3" class="usa-link">Fig. 3E</a>; <a href="#SD3" class="usa-link">Supplementary Fig. S3</a>). The tumor proliferation rate and the number of CCA-like tumors were lower in <em>sgGSK3Î±/Î²/NRas</em> mice compared to <em>Akt/NRas</em> livers (<a href="#F3" class="usa-link">Fig. 3E</a>â€“<a href="#F3" class="usa-link">G</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Concomitant deletion of GSK3Î± and GSK3Î² synergizes with activated NRas and largely recapitulates <em>Akt/NRas</em>-dependent liver tumor development.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/15d626adf479/nihms-2112487-f0003.jpg" loading="lazy" height="2100" width="1528" alt="Figure 3."></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P54"><strong>A,</strong> H&amp;E and immunohistochemistry for HA-tag, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> of liver sections from <em>Akt/NRas</em> (5.4w.p.i.). <strong>B,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>sgGFP</em> or <em>sgGSK3Î±/Î²</em> or <em>Akt</em> together with <em>NRas</em> plasmids. <strong>C,</strong> The survival curves of <em>sgGFP/NRas</em> (n=6), <em>sgGSK3Î±/Î²/NRas</em> (n=6), and <em>Akt/NRas</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>D,</strong> Western blot analyzing the protein levels of GSK3Î± and GSK3Î² in liver tissue of <em>sgGFP/NRas</em> or <em>sgGSK3Î±/Î²/NRas</em> mice. n=2 per group. GAPDH was used as the loading control. <strong>E,</strong> Representative gross images, H&amp;E and immunohistochemistry for p-Erk1/2, Ki67 and Ck19 of liver sections from <em>Akt/NRas</em> (5.4w.p.i.), <em>sgGFP/NRas</em> (9.6w.p.i.), and <em>sgGSK3Î±/Î²/NRas</em> (9.6w.p.i.) mice. IHC analysis for GSK3Î±/Î² in liver sections from <em>sgGFP/NRas</em> (9.6w.p.i.) and <em>sgGSK3Î±/Î²/NRas</em> (9.6w.p.i.) mice. Additionally, IHC for p-AKT<sup>Ser473</sup> was performed on liver sections from <em>Akt/NRas</em> (5.4w.p.i.). <strong>F</strong> and <strong>G,</strong> Quantification of the Ki67 (<strong>F</strong>) and Ck19 (<strong>G</strong>) positive staining in (<strong>E</strong>). n&gt;=18 per group. Scale bar in (<strong>A</strong> and <strong>E</strong>): 500 Î¼m (40X), 200 Î¼m (100X), and 100 Î¼m (200X). Statistical significance was determined by the two-tailed unpaired Studentâ€™s t-test in (<strong>F</strong>). Data are presented as mean Â± SD; **, ***, and **** indicate p &lt; 0.01, p &lt; 0.001, and p &lt; 0.0001, respectively. Abbreviations: H&amp;E, hematoxylin and eosin staining; NT, surrounding non-tumor sections; T, tumor sections; w.p.i., weeks post-injection.</p></figcaption></figure><p id="P29">Next, we investigated whether deleting GSK3Î± or GSK3Î² alone can synergize with activated NRas to promote HCC formation. Therefore, we co-injected either <em>sgGFP</em>, <em>sgGSK3Î±</em>, or <em>sgGSK3Î²</em> with <em>NRas</em> plasmids into <em>FVB/N</em> mice (<a href="#SD4" class="usa-link">Supplementary Fig. S4A</a>) and harvested the mice at 14 weeks post-injection. Several small tumor nodules developed in <em>sgGSK3Î±/NRas</em> and <em>sgGSK3Î²/NRas</em> mice, whereas no tumor lesions occurred in <em>sgGFP/NRas</em> mice (<a href="#SD4" class="usa-link">Supplementary Fig. S4B</a>; <a href="#SD21" class="usa-link">Supplementary Table S2</a>), in striking contrast to the numerous tumor lesions developing in <em>sgGSK3Î±/Î²/NRas</em> livers. The tumor cells were proliferative, as demonstrated by Ki67 immunoreactivity (<a href="#SD5" class="usa-link">Supplementary Fig. S5A</a> and <a href="#SD5" class="usa-link">S5B</a>). <em>sgGSK3Î±/NRas</em> and <em>sgGSK3Î²/NRas</em> lesions were predominantly HCC-like tumors with only a few CCA-like lesions (<a href="#SD5" class="usa-link">Supplementary Fig. S5A</a> and <a href="#SD5" class="usa-link">S5C</a>). The results suggest that GSK3Î± alone or GSK3Î² alone have weak tumor-suppressing roles, and the two isoforms likely function redundantly to inhibit hepatocarcinogenesis.</p>
<p id="P30">In summary, the combined loss of GSK3Î± and GSK3Î² works synergistically with activated NRas to promote liver tumor formation within a relatively short period. This finding supports the hypothesis that the GSK3 pathway may be a key signaling mechanism mediating the effects of AKT during hepatocarcinogenesis. The study also highlights the significant tumor suppressor role of GSK3Î± and GSK3Î² <em>in vivo</em>. Furthermore, the <em>sgGSK3Î±/Î²/NRas</em> model represents the first murine model of tumors induced by the simultaneous loss of <em>GSK3Î±</em> and <em>GSK3Î²</em> genes.</p></section><section id="S18"><h3 class="pmc_sec_title">AKT-mediated phosphorylation of GSK3Î±S21 and GSK3Î²S9 is the critical event in <em>Akt/NRas</em>-induced hepatocarcinogenesis</h3>
<p id="P31">To complement the studies mentioned above, we determined whether constitutively activated GSK3Î± or GSK3Î² can inhibit <em>Akt/NRas</em>-driven liver tumor formation <em>in vivo</em>, based on the observation that the immunoreactivity of p-GSK3Î±<sup>Ser21</sup> and p-GSK3Î²<sup>Ser9</sup> was higher in <em>Akt/NRas</em>-induced liver tumors than in surrounding non-tumorous tissue (<a href="#F3" class="usa-link">Fig. 3A</a>). Thus, we introduced mutations in Myc-tagged plasmids for <em>GSK3Î±</em><sup><em>Ser21</em></sup> and <em>GSK3Î²</em><sup><em>Ser9</em></sup> to substitute with alanine (<em>GSK3Î±S21A-Myc-tag</em> and <em>GSK3Î²S9A-Myc-tag</em>, respectively), which prevented their phosphorylation by AKT. Next, we co-injected the plasmids carrying either <em>GSK3Î±S21A</em>, <em>GSK3Î²S9A</em>, or a <em>pT3</em> empty vector, with activated <em>Akt</em> and <em>NRas</em> plasmids into <em>FVB/N</em> mice (<a href="#F4" class="usa-link">Fig. 4A</a>). Overexpression of <em>GSK3Î±S21A</em> or <em>GSK3Î²S9A</em> significantly delayed <em>Akt/NRas</em>-induced tumor development, as evidenced by the longer lifespan of mice injected with <em>GSK3Î±S21A</em> or <em>GSK3Î²S9A</em> plasmid compared to the control mice (<a href="#F4" class="usa-link">Fig. 4B</a>). Remarkably, smaller tumor lesions developed in <em>GSK3Î±S21A</em> and <em>GSK3Î²S9A</em> mice compared to the large tumor nodules observed in <em>Akt/NRas/pT3</em> mice at 5.4 weeks post-injection. The tumor nodules in mice injected with <em>GSK3Î±S21A</em> or <em>GSK3Î²S9A</em> only reached a late stage of development at 15 or 18 weeks post-injection, as assessed by H&amp;E staining (<a href="#F4" class="usa-link">Fig. 4C</a>). Positive immunoreactivity for p-AKT<sup>Ser473</sup> and p-ERK1/2 was detected in all tumor lesions, suggesting that AKT and NRas were still active in the tumor cells (<a href="#SD6" class="usa-link">Supplementary Fig. S6</a>). Additionally, overexpression of GSK3Î±S21A or GSK3Î²S9A reduced liver weight, cell proliferative ability (Ki67+), and CCA lesions (CK19+), at the same time point (<a href="#F4" class="usa-link">Fig. 4D</a>â€“<a href="#F4" class="usa-link">F</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. Overexpression of GSK3Î±S21A or GSK3Î²S9A significantly delays <em>Akt/NRas</em>-induced HCC development.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/4a73d6912eee/nihms-2112487-f0004.jpg" loading="lazy" height="2100" width="1458" alt="Figure 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P55"><strong>A,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>pT3</em> empty vector or <em>pT3-GSK3Î±S21A</em> or <em>pT3-GSK3Î²S9A</em> with <em>Akt</em> and <em>NRas</em> plasmids. <strong>B,</strong> The survival curves of <em>Akt/NRas/pT3</em> (n=6), <em>Akt/NRas/pT3-GSK3Î±S21A</em> (n=6), and <em>Akt/NRas/pT3-GSK3Î²S9A</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>C,</strong> Representative gross images, H&amp;E, and immunohistochemistry for Myc-tag, Ki67, and Ck19 of liver sections from <em>Akt/NRas/pT3</em> (5.4w.p.i.), <em>Akt/NRas/pT3-GSK3Î±S21A</em> (5.4w.p.i. &amp; 15w.p.i.), and <em>Akt/NRas/pT3-GSK3Î²S9A</em> (5.4w.p.i. &amp; 18w.p.i.) mice. Scale bar: 500 Î¼m (40X), 200 Î¼m (100X), and 100 Î¼m (200X). <strong>D</strong> to <strong>F</strong>, Comparisons of liver weight (<strong>D</strong>) and quantification of Ki67 (<strong>E</strong>) and Ck19 (<strong>F</strong>) positive staining in liver sections from the mice in (<strong>C</strong>) at 5.4w.p.i. n=5 per group in (<strong>D</strong>). n=18 per group in (<strong>E</strong>) and (<strong>F</strong>). Statistical significance was determined by the two-tailed unpaired Studentâ€™s t-test. Data are presented as mean Â± SD; **, ***, and **** indicate p &lt; 0.01, p &lt; 0.001, and p &lt; 0.0001, respectively. Abbreviations: H&amp;E, hematoxylin and eosin staining; NT, surrounding non-tumor sections; T, tumor sections; w.p.i., weeks post-injection.</p></figcaption></figure><p id="P32">Altogether, the results indicate that overexpression of GSK3Î±S21A or GSK3Î²S9A significantly delays <em>Akt/NRas</em>-driven tumor development, and that AKT-mediated phosphorylation of GSK3Î±S21 and GSK3Î²S9 is crucial for <em>Akt/NRas</em>-induced hepatocarcinogenesis. Therefore, the suppression of GSK3Î± and GSK3Î² activities is a critical signal mediating the AKT oncogenic potential in liver tumorigenesis.</p></section><section id="S19"><h3 class="pmc_sec_title">Distinct pathways are mediated by TSC2/mTORC1 and GSK3Î±/Î² in <em>Akt/NRas</em>-driven hepatocarcinogenesis</h3>
<p id="P33">To further illustrate the molecular mechanisms underlying TSC2/mTORC1 and GSK3Î±/Î² mediating AKT's oncogenic potential during liver tumor development, we analyzed global gene expression patterns of liver tumors collected from <em>Akt/NRas</em>, <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>, and <em>sgGSK3Î±/Î²/NRas</em> mice, with normal liver (NL) from the uninjected mice as the control (<a href="#F5" class="usa-link">Fig. 5A</a>). Principal component analysis (PCA) revealed distinct gene expression patterns of the tumors from normal liver tissues (<a href="#F5" class="usa-link">Fig. 5A</a>). Importantly, different expression profiles characterized <em>Akt/NRas</em>, <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>, and <em>sgGSK3Î±/Î²/NRas</em> liver tumors. Specifically, we identified 1700 genes up-regulated in tumor samples and 1126 genes downregulated in all tumors (<a href="#F5" class="usa-link">Fig. 5B</a>; <a href="#SD26" class="usa-link">Supplementary Data S1</a>). These genes are related to pathways involved in cancer, PI3K/AKT signaling pathway, and activated Ras/MAPK signaling pathway (<a href="#SD7" class="usa-link">Supplementary Fig. S7</a>).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5. Distinct pathways mediated by TSC2/mTORC1 and GSK3Î±/Î² in <em>Akt/NRas</em>-driven liver tumor development.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/cf4ea84ca7a6/nihms-2112487-f0005.jpg" loading="lazy" height="2100" width="1510" alt="Figure 5."></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P56"><strong>A,</strong> Principal component analysis (PCA) analyzing the global gene expression patterns of the tumors from the normal liver and liver tumor tissues from <em>Akt/NRas</em>, <em>Tsc2</em><sup>âˆ’/âˆ’</sup>/NRas, and <em>sgGSK3Î±/Î²/NRas</em> mice. <strong>B,</strong> The table shows (1) the number of up-regulated or down-regulated genes in <em>Akt/NRas</em>, <em>Tsc2</em><sup>âˆ’/âˆ’</sup>/<em>NRas</em>, and <em>sgGSK3Î±/Î²/NRas</em> liver tumors (cancer-related genes); (2) the number of up-regulated or down-regulated genes in <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup>/<em>NRas</em>, but not in <em>sgGSK3Î±/Î²/NRas</em> liver tumors (TSC2/mTORC1 regulated genes); (3) the number of up- or down-regulated genes in <em>Akt/NRas</em> and <em>sgGSK3Î±/Î²/NRas</em>, but not in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> liver tumors (GSK3Î±/Î² regulated genes). <strong>C,</strong> KEGG analysis of the up-regulated genes in <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup>/NRas, but not in <em>sgGSK3Î±/Î²/NRas</em> liver tumor (TSC2/mTORC1 upregulated genes). <strong>D,</strong> KEGG analysis of the up-regulated genes in <em>Akt/NRas</em> and <em>sgGSK3Î±/Î²/NRas</em>, but not in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> liver tumor (GSK3Î±/Î² upregulated genes). Genes were ranked by p-value &lt; 0.05.</p></figcaption></figure><p id="P34">To elucidate the unique gene expression patterns regulated by TSC2/mTORC1 or GSK3Î±/Î² signaling, we identified genes that were upregulated in <em>Akt/NRas</em> liver tumors and only upregulated in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> liver tumors, but not in <em>sgGSK3Î±/Î²/NRas</em> liver tumors as TSC2-upregulated genes (n=262) (<a href="#F5" class="usa-link">Fig. 5B</a>; <a href="#SD27" class="usa-link">Supplementary Data S2</a>). We applied a similar strategy to identify TSC2-downregulated genes (n=165) (<a href="#F5" class="usa-link">Fig. 5B</a>; <a href="#SD28" class="usa-link">Supplementary Data S3</a>), GSK3Î±/Î²-upregulated genes (n=827) (<a href="#F5" class="usa-link">Fig. 5B</a>; <a href="#SD29" class="usa-link">Supplementary Data S4</a>), and GSK3Î±/Î²-downregulated genes (n=748) (<a href="#F5" class="usa-link">Fig. 5B</a>; <a href="#SD30" class="usa-link">Supplementary Data S5</a>). Pathway analysis revealed that the TSC2/mTORC1 pathway uniquely upregulates genes involved in the actin cytoskeleton, Rap1 signaling, focal adhesion, and apoptosis in <em>Akt/NRas</em>-induced liver tumors (<a href="#F5" class="usa-link">Fig. 5C</a>; <a href="#SD8" class="usa-link">Supplementary Fig. S8A</a>). In contrast, GSK3Î±/Î² upregulated genes were primarily involved in cell cycle and DNA replication in <em>Akt/NRas</em>-induced liver tumors (<a href="#F5" class="usa-link">Fig. 5D</a>; <a href="#SD8" class="usa-link">Supplementary Fig. S8B</a>), identifying GSK3Î±/Î² as a critical AKT downstream effector promoting tumor cell proliferation. Concerning downregulated genes, TSC2/mTORC1 and GSK3Î±/Î² regulate different metabolic pathways downstream of activated AKT in HCC (<a href="#SD9" class="usa-link">Supplementary Fig. S9</a>).</p>
<p id="P35">In summary, TSC2/mTORC1 and GSK3Î±/Î² regulate distinct pathways downstream of AKT during hepatocarcinogenesis.</p></section><section id="S20"><h3 class="pmc_sec_title">The AKT/GSK3 axis regulates FOXM1 in HCC</h3>
<p id="P36">Numerous studies implied mTORC1 as the major downstream effector of AKT in tumors, including HCC(<a href="#R18" class="usa-link" aria-describedby="R18">18</a>,<a href="#R34" class="usa-link" aria-describedby="R34">34</a>,<a href="#R36" class="usa-link" aria-describedby="R36">36</a>). However, the functional role of GSK3Î±/Î² as the downstream effectors of AKT during liver tumor development remains poorly characterized. Therefore, we focused on genes uniquely regulated by GSK3Î±/Î² in the RNASeq approach and selected genes that are upregulated in human HCC samples and have prognostic values. Among these genes is forkhead box M1 (<em>Foxm1</em>), which has been previously linked to HCC(<a href="#R21" class="usa-link" aria-describedby="R21">21</a>,<a href="#R37" class="usa-link" aria-describedby="R37">37</a>). <em>Foxm1</em> expression is upregulated in human HCC samples, and high expression of <em>Foxm1</em> is associated with poor patient survival (<a href="#F6" class="usa-link">Fig. 6A</a> and <a href="#F6" class="usa-link">B</a>). Our RNAseq study revealed that <em>Foxm1</em> expression is strongly upregulated in <em>Akt/NRas</em> and <em>sgGSK3Î±/Î²/NRas</em> tumor lesions, but not in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> tumors (<a href="#F6" class="usa-link">Fig. 6C</a>).</p>
<p id="P37">As the first step to investigate the functions of FOXM1 in hepatocarcinogenesis, we analyzed genes whose expression patterns are correlated with that of <em>Foxm1</em> in human HCC samples from the TCGA database (<a href="#SD31" class="usa-link">Supplementary Data S6</a>). Pathway analysis revealed that <em>Foxm1</em> positively correlates with genes associated with cell cycle and DNA replication, and it negatively correlates with genes associated with metabolic pathways, etc. (<a href="#SD10" class="usa-link">Supplementary Fig. S10</a>). The data are consistent with the hypothesis that FOXM1 might be a key molecule downstream of AKT/GSK3 cascade in hepatocarcinogenesis (<a href="#F5" class="usa-link">Fig. 5D</a>). Next, we analyzed how FOXM1 modulates HCC cell growth <em>in vitro</em>. We retrieved the FOXM1 perturbation effect data from the DepMap portal. Notably, CRISPR-based deletion of <em>FOXM1</em> induced growth restraint in most of the HCC cell lines tested (<a href="#SD11" class="usa-link">Supplementary Fig. S11</a>), supporting the requirement of FOXM1 for HCC cell growth <em>in vitro</em>.</p>
<p id="P38">Finally, we investigate the importance of FOXM1 in <em>Akt/NRas</em>- and <em>sgGSK3Î±/Î²/NRas</em>-dependent hepatocarcinogenesis. Therefore, we designed a single guide RNA against mouse <em>Foxm1</em> and cloned it into a pX330 vector (<a href="#SD12" class="usa-link">Supplementary Fig. S12A</a>). The knock-out efficiency of <em>sgFoxm1</em> was evaluated in the mouse HCC cell line HCC3â€“4 using Western blot analysis (<a href="#SD12" class="usa-link">Supplementary Fig. S12B</a>). Subsequently, we hydrodynamically injected <em>Akt/NRas</em> plasmids with <em>sgFoxm1</em> into the mice (<a href="#F6" class="usa-link">Fig. 6D</a>). TIDE analysis showed the effectiveness of <em>sgFoxm1</em> in disrupting the <em>Foxm1</em> allele in the tumor cells (<a href="#SD12" class="usa-link">Supplementary Fig. S12C</a>). In agreement with the <em>in vitro</em> evidence, the deletion of <em>Foxm1</em> significantly delayed <em>Akt/NRas</em>-driven liver tumor formation (<a href="#F6" class="usa-link">Fig. 6E</a> and <a href="#F6" class="usa-link">F</a>). However, the eventual tumors remained proliferative as demonstrated by Ki67 IHC (<a href="#SD12" class="usa-link">Supplementary Fig. S12D</a>). The results suggested that <em>Foxm1</em> deletion suppressed but could not completely inhibit <em>Akt/NRas</em>-induced liver tumor development. Similar results were obtained in <em>sgGSK3Î±/Î²/NRas</em>-injected mice (<a href="#F6" class="usa-link">Fig. 6G</a>â€“<a href="#F6" class="usa-link">I</a>; <a href="#SD12" class="usa-link">Supplementary Fig. S12D</a>).</p>
<p id="P39">Overall, our studies suggest that FOXM1 is a major factor regulated by AKT/GSK3 in HCC.</p></section><section id="S21"><h3 class="pmc_sec_title">Concomitant deletion of GSK3Î±/Î² and TSC2 together with NRas activation rapidly induces liver tumor formation in mice</h3>
<p id="P40">Given the significant tumor suppressive roles of GSK3Î±/Î² and TSC2 proteins in hepatocarcinogenesis, we hypothesized that the concurrent deletion of the <em>GSK3Î±</em>, <em>GSK3Î²</em>, and <em>Tsc2</em> genes, along with the expression of active NRas, could drive hepatocarcinogenesis similar to that observed in <em>Akt/NRas</em> mice. To investigate this hypothesis, we co-injected <em>pCMV-Cre</em> and <em>NRas</em> plasmids into <em>Tsc2</em><sup><em>flox/flox</em></sup> mice with or without the <em>sgGSK3Î±/Î²</em> plasmid (<em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²)</em> (<a href="#F7" class="usa-link">Fig. 7A</a>). <em>Akt/NRas</em> or <em>sgGSK3Î±/Î²/NRas</em> plasmids were injected into <em>FVB/N</em> mice as a control (<a href="#F7" class="usa-link">Fig. 7A</a>). Remarkably, concomitant deletion of <em>GSK3Î±/Î²</em> and <em>Tsc2</em> induced tumor development with the same latency as observed in <em>Akt/NRas</em> mice (<a href="#F7" class="usa-link">Fig. 7B</a> and <a href="#F7" class="usa-link">C</a>). Furthermore, cell proliferative activity (Ki67+) and CCA-like lesions (CK19+) were evident in liver tumor tissue from <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> mice (<a href="#F7" class="usa-link">Fig. 7D</a>). At the histopathological level, significant differences were observed between the liver lesions of <em>Akt/NRas</em> mice and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> mice (<a href="#SD13" class="usa-link">Supplementary Fig. S13</a>). Specifically, the livers of <em>Akt/NRas</em> mice contained large lipid-rich preneoplastic cells, consistent with previous findings(<a href="#R21" class="usa-link" aria-describedby="R21">21</a>). The hepatocellular carcinoma (HCC) cells in <em>Akt/NRas</em> mice were small, highly basophilic, and contained tiny lipid droplets. Additionally, cholangiocellular and mixed hepatocellular/cholangiocellular lesions were consistently present in the <em>Akt/NRas</em> liver parenchyma (<a href="#SD13" class="usa-link">Supplementary Fig. S13A</a> and <a href="#SD13" class="usa-link">S13B</a>). In contrast, <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> livers showed no visible preneoplastic cells, indicating that lesions in this model presumably do not progress through a premalignant phase. Liver tumors were histologically less aggressive than those observed in <em>Akt/NRas</em> mice. The HCC cells in these livers were extremely large in size and displayed a large and vacuolated eosinophilic cytoplasm. While cholangiocellular lesions were present in <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> livers, they were significantly less numerous compared to those in <em>Akt/NRas</em> mice (<a href="#SD13" class="usa-link">Supplementary Fig. S13C</a> and <a href="#SD13" class="usa-link">S13D</a>).</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Figure 7. Simultaneous deletion of <em>GSK3Î±/Î²</em> and <em>Tsc2</em> and activation of NRas rapidly induces liver tumor formation, similar to that observed in <em>Akt/NRas</em> mice.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/b1e177e364b6/nihms-2112487-f0007.jpg" loading="lazy" height="2100" width="1538" alt="Figure 7."></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P58"><strong>A,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>Akt</em> or <em>sgGSK3Î±/Î²</em> together with <em>NRas</em> plasmids. <em>Tsc2</em><sup><em>flox/flox</em></sup> mice were hydrodynamically injected with either <em>pCMV-Cre/NRas</em> (<em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>) or <em>pCMV-Cre/NRas</em>/<em>sgGSK3Î±/Î²</em> (<em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em>) plasmids. <strong>B,</strong> Western blot analyzing the expression levels of TSC2, GSK3Î± and GSK3Î² in liver tissues of NL, <em>Akt/NRas</em> or <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas /sgGSK3Î±/Î²</em> mice. Î²-Actin was used as the loading control. n=3 per group. <strong>C,</strong> The survival curves of <em>Akt/NRas</em> (n=5), <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>/<em>sgGSK3Î±/Î²</em> (n=9), <em>sgGSK3Î±/Î²/NRas</em> (n=5), and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>D,</strong> Representative gross images, H&amp;E, and immunohistochemistry for Ki67 and Ck19 of liver sections from the normal liver (7.3w.p.i.), <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>/<em>sgGSK3Î±/Î²</em> (7.3w.p.i.), and <em>Akt/NRas</em> (5.3w.p.i.) mice. 3 biological replicates were performed with similar results. Scale bar: 500 Î¼m (40X), 100 Î¼m (200X), and 50 Î¼m (400X). Statistical significance: ns: not significant, p&gt;0.05, **p &lt; 0.01, ***p &lt; 0.001. Abbreviations: H&amp;E, hematoxylin and eosin staining; w.p.i., weeks post-injection.</p></figcaption></figure><p id="P41">Subsequently, we analyzed the gene expression patterns of <em>Akt/NRas</em> liver tumors versus <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> mouse liver tumors using RNASeq (<a href="#SD14" class="usa-link">Supplementary Fig. S14A</a>). We identified 2342 commonly upregulated genes compared to the normal liver in both <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> liver tumors, and these genes were involved in cancer pathways, PI3K/AKT signaling, MAPK, cell cycle, etc. (<a href="#SD14" class="usa-link">Supplementary Fig. S14B</a> and <a href="#SD14" class="usa-link">S14C</a>). We also identified 1695 genes that were commonly downregulated compared to normal liver, involved in metabolic pathways (<a href="#SD14" class="usa-link">Supplementary Fig. S14B</a> and <a href="#SD14" class="usa-link">S14D</a>). Intriguingly, we discovered significant differences in the overall gene expression patterns between the two liver tumor specimens (<a href="#SD14" class="usa-link">Supplementary Fig. S14A</a> and <a href="#SD14" class="usa-link">S14B</a>). For instance, transcriptional misregulation in cancer and Notch signaling were uniquely upregulated in <em>Akt/NRas</em> liver tumor tissues (<a href="#SD15" class="usa-link">Supplementary Fig. S15</a>).</p>
<p id="P42">These results indicate that simultaneous deletion of <em>GSK3Î±/Î²</em> and <em>Tsc2</em> and activation of NRas rapidly induce liver tumor formation, similar to that observed in <em>Akt/NRas</em> mice. Nevertheless, histopathologic and gene expression analyses strongly suggest that additional genes or pathways might function as modifiers, leading to the additional changes responsible for the diverse morphologic and molecular phenotypes observed in <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> mice.</p></section><section id="S22"><h3 class="pmc_sec_title">Activated AKT is associated with the inactivation of GSK3Î±/Î² in human HCC samples</h3>
<p id="P43">Our study demonstrates that inactivation of GSK3Î±/Î² and activation of mTORC1 may be key signaling events downstream of activated AKT during hepatocarcinogenesis. Therefore, we first analyzed the activation/inactivation status of AKT (p-AKT) and GSK3Î±/Î² (p-GSK3Î± and p-GSK3Î²) in our collection of human HCC samples (n=108). Immunoreactivity for activated/phosphorylated AKT (p-AKT) could be found in 43/108 (40%) of HCC samples analyzed, whereas inactivated/phosphorylated GSK3Î± and/or 3Î² could be seen in 50/108 (46%) of cases (<a href="#F8" class="usa-link">Fig. 8A</a> and <a href="#F8" class="usa-link">B</a>). Importantly, 40/43 (93%) p-AKT (+) human HCCs demonstrated either p-GSK3Î± and/or -3Î² immunoreactivity (<a href="#F8" class="usa-link">Fig. 8A</a>â€“<a href="#F8" class="usa-link">C</a>). In contrast, 55/65 (85%) of p-AKT (â€“) HCCs were negative for both GSK3Î± and 3Î² (<a href="#F8" class="usa-link">Fig. 8A</a> and <a href="#F8" class="usa-link">B</a>). The difference was found to be statistically significant (<a href="#F8" class="usa-link">Fig. 8D</a>). Furthermore, analysis of The Cancer Proteome Atlas (TCPA) data revealed a strong positive correlation between p-AKT<sup>Ser473</sup>/p-GSK3<sup>Ser9</sup> and FOXM1 expression in human HCC samples (n = 184) (<a href="#F8" class="usa-link">Fig. 8E</a>; <a href="#SD16" class="usa-link">Supplementary Fig. S16</a>), supporting the hypothesis that the GSK3Î±/Î²â€“FOXM1 cascade is a key signaling axis downstream of activated AKT during hepatocarcinogenesis.</p>
<p id="P44">We next examined mTORC1 activation in human HCC samples. In line with findings from the <em>Akt/NRas</em> HCC mouse model, TCPA data showed a strong positive correlation between p-AKT<sup>Ser473</sup> and mTORC1 activation markers, including p-mTOR<sup>Ser2448</sup> and p-P70S6K<sup>Thr389</sup> (<a href="#SD17" class="usa-link">Supplementary Fig. S17</a>), indicating that mTORC1 activation is closely associated with AKT signaling in human HCC. Additionally, mTORC1 activation positively correlated with GSK3 inactivation in the same cohort, suggesting that mTORC1 activation and GSK3Î±/Î² inactivation co-occur in AKT-driven human HCC (<a href="#SD18" class="usa-link">Supplementary Fig. S18</a>). Together with the findings from mouse models, these human data further support that GSK3/FOXM1 and TSC2/mTORC1 pathways are major downstream effectors of AKT activation in hepatocarcinogenesis.</p></section></section><section id="S23"><h2 class="pmc_sec_title">Discussion</h2>
<p id="P45">The PI3K/AKT pathway plays a crucial role in the development and progression of hepatocellular carcinoma (HCC). However, the specific mechanisms through which AKT promotes its oncogenic activity in liver cancer formation are still not fully understood. In this study, we systematically examined the functional significance of three key downstream effectors of oncogenic AKT signaling: Foxo, TSC/mTORC1, and GSK3Î±/Î², in the context of hepatocarcinogenesis.</p>
<p id="P46">The first conclusion from this study is that the Foxo pathway has a limited role in the formation of AKT-driven hepatocellular carcinoma (HCC). This finding contrasts with previous studies, which indicated that the loss of Foxo1 could rescue defects in insulin signaling and liver regeneration resulting from the ablation of <em>Akt1/2</em>(<a href="#R14" class="usa-link" aria-describedby="R14">14</a>,<a href="#R38" class="usa-link" aria-describedby="R38">38</a>). Here, we found that the loss of <em>Foxo1</em> did not significantly cooperate with activated Ras to induce HCC formation. Importantly, overexpression of the constitutively activated form of Foxo1 (Foxo1AAA) did not inhibit liver tumor formation induced by <em>Akt/NRas</em>. These data suggest that the loss of Foxo1 might occur later during HCC progression, at least in tumors co-expressing activated NRas and AKT. However, our findings do not exclude the possibility that the loss of Foxo1 function may still regulate HCC cells at the molecular level. To investigate this hypothesis, we performed RNA sequencing analysis comparing <em>Akt/NRas</em> tumors with <em>Akt/NRas/Foxo1AAA</em> tumors. We identified 506 genes that are differentially expressed between the two tumor types (<a href="#SD19" class="usa-link">Supplementary Fig. S19</a>; <a href="#SD32" class="usa-link">Supplementary Data S7</a>). The results indicate that Foxo1 may influence other tumor properties, such as differentiation status and drug resistance. Further analysis will be necessary to elucidate the roles of Foxo1 protein during hepatocarcinogenesis.</p>
<p id="P47">The mTOR pathway has been considered the major signaling event downstream of activated AKT. We have previously shown that loss of mTORC1 via deleting its unique subunit Raptor completely suppresses <em>Akt/NRas</em>-driven HCC formation(<a href="#R34" class="usa-link" aria-describedby="R34">34</a>), revealing that mTORC1 is required for tumor development. In the current study, using conditional <em>Tsc2</em> KO mice, we demonstrated that activation of mTORC1 alone cooperates with activated RAS to promote HCC formation, albeit after longer latency, and the tumors appeared to be much less aggressive. RNAseq analysis revealed the distinct gene expression patterns between <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em> liver tumor specimens. These data indicate that additional signaling pathways are required downstream of AKT in addition to the activated mTORC1 to promote HCC progression and aggressiveness.</p>
<p id="P48">The third pathway that we analyzed is GSK3Î±/Î² signaling in AKT-driven liver tumor development. Using human HCC samples, we demonstrated that activated AKT is frequently associated with the increased phosphorylation/inactivation of GSK3Î± and/or GSK3Î² (<a href="#F8" class="usa-link">Fig. 8</a>). Notably, we show here that the ablation of GSK3Î±/Î² synergizes with NRas to promote HCC formation, albeit after slightly longer latency then that detected in <em>Akt/NRas</em> mice. To the best of our knowledge, this is the first murine model with loss of <em>GSK3Î±/Î²</em> and represents a new tool to study this tumor suppressor pathway in tumor development. RNAseq analysis revealed that GSK3Î±/Î² controlled major signaling events downstream of activated AKT in HCC, including cell proliferation. Importantly, we identified FOXM1 as a target downregulated by AKT/GSK3Î±/Î² in HCC. CRISPR/Cas9-mediated knockout of <em>Foxm1</em> significantly delayed HCC formation in <em>Akt/NRas</em> and <em>sgGSK3Î±/Î²/NRas</em> mouse models (<a href="#F6" class="usa-link">Fig. 6</a>). These data unravel the key role of the GSK3Î±/Î²/FOXM1 axis during hepatocarcinogenesis. The precise mechanisms by which FOXM1 is regulated by AKT/GSK3 cascade require further investigation. As GSK3Î±/Î² are kinases, it is likely that their regulation of <em>Foxm1</em> at mRNA levels is indirect. One possible link is that GSK3Î±/Î² are known to regulate the stability of YAP (<a href="#R39" class="usa-link" aria-describedby="R39">39</a>). Multiple studies have shown that FOXM1 is a direct target of YAP (<a href="#R40" class="usa-link" aria-describedby="R40">40</a>,<a href="#R41" class="usa-link" aria-describedby="R41">41</a>). It would be important to investigate whether FOXM1 is regulated by AKT/GSK3 cascade via YAP during HCC pathogenesis.</p>
<p id="P49">Finally, we showed that simultaneous deletion of GSK3Î±&amp;3Î² and activated mTORC1 synergize with activated NRas to rapidly induce liver tumor formation in mice, recapitulating <em>Akt/NRas</em>-induced hepatocarcinogenesis. These results provide strong evidence that GSK3Î±/Î² and TSC/mTORC1 cascades are the major cellular events that act downstream of activated AKT to promote liver tumorigenesis. Intriguingly, RNAseq studies revealed that at the molecular level, distinct gene expression patterns between <em>Akt/NRas</em> and <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas/sgGSK3Î±/Î²</em> mouse liver tumors were unveiled. The results indicate that other pathways may play significant roles in modulating tumor expression patterns without directly influencing tumor formation. As we discussed earlier, one of these signaling pathways involves the Foxo family of members. In fact, further RNA sequencing studies showed that Foxo1AAA was capable of regulating several pathways in <em>Akt/NRas</em> tumors.</p>
<p id="P50">The study demonstrates that the GSK3Î±/Î² and TSC/mTORC1 pathways play crucial roles as downstream effectors in AKT-driven hepatocarcinogenesis. Additionally, Foxo proteins may act as molecular modifiers in this process. Our findings carry significant translational implications, suggesting that targeting both the TSC/mTORC1 and GSK3Î±/Î² pathways may be important for treating human HCC subsets with activated AKT.</p></section><section id="SM1"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="SD1"><div class="caption p"><span>1</span></div>
<div class="media p" id="d67e2148"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-1.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-1.pdf</a><sup> (184.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD2"><div class="caption p"><span>2</span></div>
<div class="media p" id="d67e2151"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-2.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-2.pdf</a><sup> (664.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD3"><div class="caption p"><span>3</span></div>
<div class="media p" id="d67e2154"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-3.pdf</a><sup> (4.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD4"><div class="caption p"><span>4</span></div>
<div class="media p" id="d67e2157"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-4.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-4.pdf</a><sup> (798.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD5"><div class="caption p"><span>5</span></div>
<div class="media p" id="d67e2160"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-5.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-5.pdf</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD6"><div class="caption p"><span>6</span></div>
<div class="media p" id="d67e2163"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-6.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-6.pdf</a><sup> (361KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD7"><div class="caption p"><span>7</span></div>
<div class="media p" id="d67e2166"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-7.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-7.pdf</a><sup> (937.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD8"><div class="caption p"><span>8</span></div>
<div class="media p" id="d67e2169"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-8.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-8.pdf</a><sup> (1.1MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD9"><div class="caption p"><span>9</span></div>
<div class="media p" id="d67e2172"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-9.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-9.pdf</a><sup> (1MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD10"><div class="caption p"><span>10</span></div>
<div class="media p" id="d67e2175"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-10.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-10.pdf</a><sup> (215.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD11"><div class="caption p"><span>11</span></div>
<div class="media p" id="d67e2179"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-11.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-11.pdf</a><sup> (109KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD12"><div class="caption p"><span>12</span></div>
<div class="media p" id="d67e2182"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-12.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-12.pdf</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD13"><div class="caption p"><span>13</span></div>
<div class="media p" id="d67e2185"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-13.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-13.pdf</a><sup> (716.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD14"><div class="caption p"><span>14</span></div>
<div class="media p" id="d67e2188"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-14.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-14.pdf</a><sup> (951KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD15"><div class="caption p"><span>15</span></div>
<div class="media p" id="d67e2191"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-15.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-15.pdf</a><sup> (976.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD16"><div class="caption p"><span>16</span></div>
<div class="media p" id="d67e2194"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-16.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-16.pdf</a><sup> (70.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD17"><div class="caption p"><span>17</span></div>
<div class="media p" id="d67e2197"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-17.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-17.pdf</a><sup> (105.8KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD18"><div class="caption p"><span>18</span></div>
<div class="media p" id="d67e2200"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-18.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-18.pdf</a><sup> (104KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD19"><div class="caption p"><span>19</span></div>
<div class="media p" id="d67e2203"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-19.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-19.pdf</a><sup> (206.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD20"><div class="caption p"><span>20</span></div>
<div class="media p" id="d67e2206"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-20.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-20.docx</a><sup> (35.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD21"><div class="caption p"><span>21</span></div>
<div class="media p" id="d67e2209"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-21.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-21.docx</a><sup> (54.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD22"><div class="caption p"><span>22</span></div>
<div class="media p" id="d67e2213"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-22.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-22.docx</a><sup> (35.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD23"><div class="caption p"><span>23</span></div>
<div class="media p" id="d67e2216"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-23.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-23.docx</a><sup> (33.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD24"><div class="caption p"><span>24</span></div>
<div class="media p" id="d67e2219"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-24.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-24.docx</a><sup> (34.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD25"><div class="caption p"><span>25</span></div>
<div class="media p" id="d67e2222"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-25.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-25.docx</a><sup> (37.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD26"><div class="caption p"><span>26</span></div>
<div class="media p" id="d67e2225"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-26.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-26.xlsx</a><sup> (678.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD27"><div class="caption p"><span>27</span></div>
<div class="media p" id="d67e2228"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-27.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-27.xlsx</a><sup> (70.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD28"><div class="caption p"><span>28</span></div>
<div class="media p" id="d67e2231"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-28.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-28.xlsx</a><sup> (48.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD29"><div class="caption p"><span>29</span></div>
<div class="media p" id="d67e2234"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-29.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-29.xlsx</a><sup> (201.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD30"><div class="caption p"><span>30</span></div>
<div class="media p" id="d67e2237"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-30.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-30.xlsx</a><sup> (188.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD31"><div class="caption p"><span>31</span></div>
<div class="media p" id="d67e2240"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-31.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-31.xlsx</a><sup> (148.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SD32"><div class="caption p"><span>32</span></div>
<div class="media p" id="d67e2243"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-32.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-32.xlsx</a><sup> (37.4KB, xlsx) </sup>
</div></div></section></section><section id="floats-group1" class="floats-group"><section class="bt xbox font-sm" id="BX1"><h2 class="obj_head">Statement of significance:</h2>
<p id="P60">GSK3Î±/Î² and TSC2/mTORC1 are key downstream effectors of AKT in liver tumorigenesis that can potentially be targeted to benefit patients with hepatocellular carcinoma harboring aberrantly activated AKT.</p></section></section><section id="S24" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p id="P51">We would like to acknowledge the support from the UH Cancer Center Microscopy, Imaging, and Flow Cytometry Core. This study is supported by National Institutes of Health (NIH) grants R01CA250227, R01CA239251, R01CA221916, and R01CA228483 to X.C., and Sichuan Science and Technology Program (no. 2024NSFSC0058) to S.Z.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN2">
<p id="P62">Authorsâ€™ Disclosures</p>
<p id="P63">The authors have declared that no conflict of interest exists.</p>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. 
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin
2021;71:209â€“49
</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Global%20Cancer%20Statistics%202020:%20GLOBOCAN%20Estimates%20of%20Incidence%20and%20Mortality%20Worldwide%20for%2036%20Cancers%20in%20185%20Countries&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;author=M%20Laversanne&amp;author=I%20Soerjomataram&amp;volume=71&amp;publication_year=2021&amp;pages=209-49&amp;pmid=33538338&amp;doi=10.3322/caac.21660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Medavaram S, Zhang Y. Emerging therapies in advanced hepatocellular carcinoma. Experimental hematology &amp; oncology
2018;7:17.
</cite> [<a href="https://doi.org/10.1186/s40164-018-0109-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6076403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30087805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20hematology%20&amp;%20oncology&amp;title=Emerging%20therapies%20in%20advanced%20hepatocellular%20carcinoma&amp;author=S%20Medavaram&amp;author=Y%20Zhang&amp;volume=7&amp;publication_year=2018&amp;pages=17&amp;pmid=30087805&amp;doi=10.1186/s40164-018-0109-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. 
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. The Lancet Oncology
2009;10:25â€“34
</cite> [<a href="https://doi.org/10.1016/S1470-2045(08)70285-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19095497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Lancet%20Oncology&amp;title=Efficacy%20and%20safety%20of%20sorafenib%20in%20patients%20in%20the%20Asia-Pacific%20region%20with%20advanced%20hepatocellular%20carcinoma:%20a%20phase%20III%20randomised,%20double-blind,%20placebo-controlled%20trial&amp;author=AL%20Cheng&amp;author=YK%20Kang&amp;author=Z%20Chen&amp;author=CJ%20Tsao&amp;author=S%20Qin&amp;volume=10&amp;publication_year=2009&amp;pages=25-34&amp;pmid=19095497&amp;doi=10.1016/S1470-2045(08)70285-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. 
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med
2008;359:378â€“90
</cite> [<a href="https://doi.org/10.1056/NEJMoa0708857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18650514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Sorafenib%20in%20advanced%20hepatocellular%20carcinoma&amp;author=JM%20Llovet&amp;author=S%20Ricci&amp;author=V%20Mazzaferro&amp;author=P%20Hilgard&amp;author=E%20Gane&amp;volume=359&amp;publication_year=2008&amp;pages=378-90&amp;pmid=18650514&amp;doi=10.1056/NEJMoa0708857&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. 
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet
2018;391:1163â€“73
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)30207-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29433850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Lenvatinib%20versus%20sorafenib%20in%20first-line%20treatment%20of%20patients%20with%20unresectable%20hepatocellular%20carcinoma:%20a%20randomised%20phase%203%20non-inferiority%20trial&amp;author=M%20Kudo&amp;author=RS%20Finn&amp;author=S%20Qin&amp;author=KH%20Han&amp;author=K%20Ikeda&amp;volume=391&amp;publication_year=2018&amp;pages=1163-73&amp;pmid=29433850&amp;doi=10.1016/S0140-6736(18)30207-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Manning BD, Toker A. AKT/PKB Signaling: Navigating the Network. Cell
2017;169:381â€“405
</cite> [<a href="https://doi.org/10.1016/j.cell.2017.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5546324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28431241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=AKT/PKB%20Signaling:%20Navigating%20the%20Network&amp;author=BD%20Manning&amp;author=A%20Toker&amp;volume=169&amp;publication_year=2017&amp;pages=381-405&amp;pmid=28431241&amp;doi=10.1016/j.cell.2017.04.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Psyrri A, Arkadopoulos N, Vassilakopoulou M, Smyrniotis V, Dimitriadis G. Pathways and targets in hepatocellular carcinoma. Expert review of anticancer therapy
2012;12:1347â€“57
</cite> [<a href="https://doi.org/10.1586/era.12.113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23176622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20review%20of%20anticancer%20therapy&amp;title=Pathways%20and%20targets%20in%20hepatocellular%20carcinoma&amp;author=A%20Psyrri&amp;author=N%20Arkadopoulos&amp;author=M%20Vassilakopoulou&amp;author=V%20Smyrniotis&amp;author=G%20Dimitriadis&amp;volume=12&amp;publication_year=2012&amp;pages=1347-57&amp;pmid=23176622&amp;doi=10.1586/era.12.113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Scheiter A, Evert K, Reibenspies L, Cigliano A, Annweiler K, MÃ¼ller K, et al. 
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues. Molecular oncology
2022;16:1091â€“118
</cite> [<a href="https://doi.org/10.1002/1878-0261.13135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8895452/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34748271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20oncology&amp;title=RASSF1A%20independence%20and%20early%20galectin-1%20upregulation%20in%20PIK3CA-induced%20hepatocarcinogenesis:%20new%20therapeutic%20venues&amp;author=A%20Scheiter&amp;author=K%20Evert&amp;author=L%20Reibenspies&amp;author=A%20Cigliano&amp;author=K%20Annweiler&amp;volume=16&amp;publication_year=2022&amp;pages=1091-118&amp;pmid=34748271&amp;doi=10.1002/1878-0261.13135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. 
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell
1999;96:857â€“68
</cite> [<a href="https://doi.org/10.1016/s0092-8674(00)80595-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10102273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Akt%20promotes%20cell%20survival%20by%20phosphorylating%20and%20inhibiting%20a%20Forkhead%20transcription%20factor&amp;author=A%20Brunet&amp;author=A%20Bonni&amp;author=MJ%20Zigmond&amp;author=MZ%20Lin&amp;author=P%20Juo&amp;volume=96&amp;publication_year=1999&amp;pages=857-68&amp;pmid=10102273&amp;doi=10.1016/s0092-8674(00)80595-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Paradis S, Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev
1998;12:2488â€“98
</cite> [<a href="https://doi.org/10.1101/gad.12.16.2488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC317081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9716402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Dev&amp;title=Caenorhabditis%20elegans%20Akt/PKB%20transduces%20insulin%20receptor-like%20signals%20from%20AGE-1%20PI3%20kinase%20to%20the%20DAF-16%20transcription%20factor&amp;author=S%20Paradis&amp;author=G%20Ruvkun&amp;volume=12&amp;publication_year=1998&amp;pages=2488-98&amp;pmid=9716402&amp;doi=10.1101/gad.12.16.2488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell
2002;10:151â€“62
</cite> [<a href="https://doi.org/10.1016/s1097-2765(02)00568-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12150915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell&amp;title=Identification%20of%20the%20tuberous%20sclerosis%20complex-2%20tumor%20suppressor%20gene%20product%20tuberin%20as%20a%20target%20of%20the%20phosphoinositide%203-kinase/akt%20pathway&amp;author=BD%20Manning&amp;author=AR%20Tee&amp;author=MN%20Logsdon&amp;author=J%20Blenis&amp;author=LC%20Cantley&amp;volume=10&amp;publication_year=2002&amp;pages=151-62&amp;pmid=12150915&amp;doi=10.1016/s1097-2765(02)00568-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature
1995;378:785â€“9
</cite> [<a href="https://doi.org/10.1038/378785a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8524413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Inhibition%20of%20glycogen%20synthase%20kinase-3%20by%20insulin%20mediated%20by%20protein%20kinase%20B&amp;author=DA%20Cross&amp;author=DR%20Alessi&amp;author=P%20Cohen&amp;author=M%20Andjelkovich&amp;author=BA%20Hemmings&amp;volume=378&amp;publication_year=1995&amp;pages=785-9&amp;pmid=8524413&amp;doi=10.1038/378785a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Garcia-Lezana T, Lopez-Canovas JL, Villanueva A. Signaling pathways in hepatocellular carcinoma. Advances in cancer research
2021;149:63â€“101
</cite> [<a href="https://doi.org/10.1016/bs.acr.2020.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33579428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20cancer%20research&amp;title=Signaling%20pathways%20in%20hepatocellular%20carcinoma&amp;author=T%20Garcia-Lezana&amp;author=JL%20Lopez-Canovas&amp;author=A%20Villanueva&amp;volume=149&amp;publication_year=2021&amp;pages=63-101&amp;pmid=33579428&amp;doi=10.1016/bs.acr.2020.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Lu M, Wan M, Leavens KF, Chu Q, Monks BR, Fernandez S, et al. 
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med
2012;18:388â€“95
</cite> [<a href="https://doi.org/10.1038/nm.2686" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3296881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22344295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Insulin%20regulates%20liver%20metabolism%20in%20vivo%20in%20the%20absence%20of%20hepatic%20Akt%20and%20Foxo1&amp;author=M%20Lu&amp;author=M%20Wan&amp;author=KF%20Leavens&amp;author=Q%20Chu&amp;author=BR%20Monks&amp;volume=18&amp;publication_year=2012&amp;pages=388-95&amp;pmid=22344295&amp;doi=10.1038/nm.2686&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Huynh H, Hao HX, Chan SL, Chen D, Ong R, Soo KC, et al. 
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus. Mol Cancer Ther
2015;14:1224â€“35
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-14-0768" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25724664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&amp;title=Loss%20of%20Tuberous%20Sclerosis%20Complex%202%20(TSC2)%20Is%20Frequent%20in%20Hepatocellular%20Carcinoma%20and%20Predicts%20Response%20to%20mTORC1%20Inhibitor%20Everolimus&amp;author=H%20Huynh&amp;author=HX%20Hao&amp;author=SL%20Chan&amp;author=D%20Chen&amp;author=R%20Ong&amp;volume=14&amp;publication_year=2015&amp;pages=1224-35&amp;pmid=25724664&amp;doi=10.1158/1535-7163.MCT-14-0768&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Burris HA, 3rd. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer chemotherapy and pharmacology
2013;71:829â€“42
</cite> [<a href="https://doi.org/10.1007/s00280-012-2043-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23377372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20chemotherapy%20and%20pharmacology&amp;title=3rd.%20Overcoming%20acquired%20resistance%20to%20anticancer%20therapy:%20focus%20on%20the%20PI3K/AKT/mTOR%20pathway&amp;author=HA%20Burris&amp;volume=71&amp;publication_year=2013&amp;pages=829-42&amp;pmid=23377372&amp;doi=10.1007/s00280-012-2043-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Dey N, De P, Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials. Pharmacol Ther
2017;175:91â€“106
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2017.02.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28216025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Ther&amp;title=PI3K-AKT-mTOR%20inhibitors%20in%20breast%20cancers:%20From%20tumor%20cell%20signaling%20to%20clinical%20trials&amp;author=N%20Dey&amp;author=P%20De&amp;author=B%20Leyland-Jones&amp;volume=175&amp;publication_year=2017&amp;pages=91-106&amp;pmid=28216025&amp;doi=10.1016/j.pharmthera.2017.02.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, et al. 
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology
2011;140:1071â€“83
</cite> [<a href="https://doi.org/10.1053/j.gastro.2010.12.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3057329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21147110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Increased%20lipogenesis,%20induced%20by%20AKT-mTORC1-RPS6%20signaling,%20promotes%20development%20of%20human%20hepatocellular%20carcinoma&amp;author=DF%20Calvisi&amp;author=C%20Wang&amp;author=C%20Ho&amp;author=S%20Ladu&amp;author=SA%20Lee&amp;volume=140&amp;publication_year=2011&amp;pages=1071-83&amp;pmid=21147110&amp;doi=10.1053/j.gastro.2010.12.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Huang KT, Huang YH, Li P, He B, Chen ZK, Yu X, et al. 
Correlation between tuberous sclerosis complex 2 and glycogen synthase kinase 3 beta levels, and outcomes of patients with hepatocellular carcinoma treated by hepatectomy. Hepatology research : the official journal of the Japan Society of Hepatology
2014;44:1142â€“50
</cite> [<a href="https://doi.org/10.1111/hepr.12256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24119083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology%20research%20:%20the%20official%20journal%20of%20the%20Japan%20Society%20of%20Hepatology&amp;title=Correlation%20between%20tuberous%20sclerosis%20complex%202%20and%20glycogen%20synthase%20kinase%203%20beta%20levels,%20and%20outcomes%20of%20patients%20with%20hepatocellular%20carcinoma%20treated%20by%20hepatectomy&amp;author=KT%20Huang&amp;author=YH%20Huang&amp;author=P%20Li&amp;author=B%20He&amp;author=ZK%20Chen&amp;volume=44&amp;publication_year=2014&amp;pages=1142-50&amp;pmid=24119083&amp;doi=10.1111/hepr.12256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Ban KC, Singh H, Krishnan R, Seow HF. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. Cancer Lett
2003;199:201â€“8
</cite> [<a href="https://doi.org/10.1016/s0304-3835(03)00421-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12969793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=GSK-3beta%20phosphorylation%20and%20alteration%20of%20beta-catenin%20in%20hepatocellular%20carcinoma&amp;author=KC%20Ban&amp;author=H%20Singh&amp;author=R%20Krishnan&amp;author=HF%20Seow&amp;volume=199&amp;publication_year=2003&amp;pages=201-8&amp;pmid=12969793&amp;doi=10.1016/s0304-3835(03)00421-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Ho C, Wang C, Mattu S, Destefanis G, Ladu S, Delogu S, et al. 
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology (Baltimore, Md)
2012;55:833â€“45</cite> [<a href="https://doi.org/10.1002/hep.24736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3269553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21993994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology%20(Baltimore,%20Md)&amp;title=AKT%20(v-akt%20murine%20thymoma%20viral%20oncogene%20homolog%201)%20and%20N-Ras%20(neuroblastoma%20ras%20viral%20oncogene%20homolog)%20coactivation%20in%20the%20mouse%20liver%20promotes%20rapid%20carcinogenesis%20by%20way%20of%20mTOR%20(mammalian%20target%20of%20rapamycin%20complex%201),%20FOXM1%20(forkhead%20box%20M1)/SKP2,%20and%20c-Myc%20pathways&amp;author=C%20Ho&amp;author=C%20Wang&amp;author=S%20Mattu&amp;author=G%20Destefanis&amp;author=S%20Ladu&amp;volume=55&amp;publication_year=2012&amp;pages=833-45&amp;pmid=21993994&amp;doi=10.1002/hep.24736&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Zhou Y, Zhang S, Qiu G, Wang X, Yonemura A, Xu H, et al. 
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein M. J Clin Invest
2024;134</cite> [<a href="https://doi.org/10.1172/JCI174415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11563669/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39325536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Invest&amp;title=TSC/mTORC1%20mediates%20mTORC2/AKT1%20signaling%20in%20c-MYC-induced%20murine%20hepatocarcinogenesis%20via%20centromere%20protein%20M&amp;author=Y%20Zhou&amp;author=S%20Zhang&amp;author=G%20Qiu&amp;author=X%20Wang&amp;author=A%20Yonemura&amp;volume=134&amp;publication_year=2024&amp;pmid=39325536&amp;doi=10.1172/JCI174415&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Chen X, Calvisi DF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. The American journal of pathology
2014;184:912â€“23
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2013.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3969989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24480331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20American%20journal%20of%20pathology&amp;title=Hydrodynamic%20transfection%20for%20generation%20of%20novel%20mouse%20models%20for%20liver%20cancer%20research&amp;author=X%20Chen&amp;author=DF%20Calvisi&amp;volume=184&amp;publication_year=2014&amp;pages=912-23&amp;pmid=24480331&amp;doi=10.1016/j.ajpath.2013.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Zhang Y, Xu H, Cui G, Liang B, Chen X, Ko S, et al. 
Î²-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma. Gastroenterology
2022</cite> [<a href="https://doi.org/10.1053/j.gastro.2022.04.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9329198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35489428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=%CE%B2-Catenin%20Sustains%20and%20Is%20Required%20for%20YES-associated%20Protein%20Oncogenic%20Activity%20in%20Cholangiocarcinoma&amp;author=Y%20Zhang&amp;author=H%20Xu&amp;author=G%20Cui&amp;author=B%20Liang&amp;author=X%20Chen&amp;publication_year=2022&amp;pmid=35489428&amp;doi=10.1053/j.gastro.2022.04.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Wang H, Wang J, Zhang S, Jia J, Liu X, Zhang J, et al. 
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. Cell Mol Gastroenterol Hepatol
2021;11:1095â€“117
</cite> [<a href="https://doi.org/10.1016/j.jcmgh.2020.11.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7903139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33232824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Gastroenterol%20Hepatol&amp;title=Distinct%20and%20Overlapping%20Roles%20of%20Hippo%20Effectors%20YAP%20and%20TAZ%20During%20Human%20and%20Mouse%20Hepatocarcinogenesis&amp;author=H%20Wang&amp;author=J%20Wang&amp;author=S%20Zhang&amp;author=J%20Jia&amp;author=X%20Liu&amp;volume=11&amp;publication_year=2021&amp;pages=1095-117&amp;pmid=33232824&amp;doi=10.1016/j.jcmgh.2020.11.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, et al. 
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res
2011;71:2286â€“97
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-10-3367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3059327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21262914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=MYC%20phosphorylation,%20activation,%20and%20tumorigenic%20potential%20in%20hepatocellular%20carcinoma%20are%20regulated%20by%20HMG-CoA%20reductase&amp;author=Z%20Cao&amp;author=H%20Fan-Minogue&amp;author=DI%20Bellovin&amp;author=A%20Yevtodiyenko&amp;author=J%20Arzeno&amp;volume=71&amp;publication_year=2011&amp;pages=2286-97&amp;pmid=21262914&amp;doi=10.1158/0008-5472.CAN-10-3367&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Xu Z, Xu M, Liu P, Zhang S, Shang R, Qiao Y, et al. 
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans. Hepatology
2019;70:1600â€“13
</cite> [<a href="https://doi.org/10.1002/hep.30697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7195156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31062368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The%20mTORC2-Akt1%20Cascade%20Is%20Crucial%20for%20c-Myc%20to%20Promote%20Hepatocarcinogenesis%20in%20Mice%20and%20Humans&amp;author=Z%20Xu&amp;author=M%20Xu&amp;author=P%20Liu&amp;author=S%20Zhang&amp;author=R%20Shang&amp;volume=70&amp;publication_year=2019&amp;pages=1600-13&amp;pmid=31062368&amp;doi=10.1002/hep.30697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Young L, Sung J, Stacey G, Masters JR. Detection of Mycoplasma in cell cultures. Nat Protoc
2010;5:929â€“34
</cite> [<a href="https://doi.org/10.1038/nprot.2010.43" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20431538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Protoc&amp;title=Detection%20of%20Mycoplasma%20in%20cell%20cultures&amp;author=L%20Young&amp;author=J%20Sung&amp;author=G%20Stacey&amp;author=JR%20Masters&amp;volume=5&amp;publication_year=2010&amp;pages=929-34&amp;pmid=20431538&amp;doi=10.1038/nprot.2010.43&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Zhou Y, Cui G, Xu H, Chun J, Yang D, Zhang Z, et al. 
Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis. Cell Death Dis
2023;14:476.
</cite> [<a href="https://doi.org/10.1038/s41419-023-05958-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10374654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37500626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Loss%20of%20TP53%20cooperates%20with%20c-MET%20overexpression%20to%20drive%20hepatocarcinogenesis&amp;author=Y%20Zhou&amp;author=G%20Cui&amp;author=H%20Xu&amp;author=J%20Chun&amp;author=D%20Yang&amp;volume=14&amp;publication_year=2023&amp;pages=476&amp;pmid=37500626&amp;doi=10.1038/s41419-023-05958-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Lu X, Deng S, Xu J, Green BL, Zhang H, Cui G, et al. 
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. J Clin Invest
2023;133</cite> [<a href="https://doi.org/10.1172/JCI163291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10231990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37040183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Invest&amp;title=Combination%20of%20AFP%20vaccine%20and%20immune%20checkpoint%20inhibitors%20slows%20hepatocellular%20carcinoma%20progression%20in%20preclinical%20models&amp;author=X%20Lu&amp;author=S%20Deng&amp;author=J%20Xu&amp;author=BL%20Green&amp;author=H%20Zhang&amp;volume=133&amp;publication_year=2023&amp;pmid=37040183&amp;doi=10.1172/JCI163291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Deng S, Lu X, Wang X, Liang B, Xu H, Yang D, et al. 
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma. Cell Death Dis
2024;15:441.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06839-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11193761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38909034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Overexpression%20of%20TBX3%20suppresses%20tumorigenesis%20in%20experimental%20and%20human%20cholangiocarcinoma&amp;author=S%20Deng&amp;author=X%20Lu&amp;author=X%20Wang&amp;author=B%20Liang&amp;author=H%20Xu&amp;volume=15&amp;publication_year=2024&amp;pages=441&amp;pmid=38909034&amp;doi=10.1038/s41419-024-06839-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Tikhanovich I, Cox J, Weinman SA. Forkhead box class O transcription factors in liver function and disease. Journal of gastroenterology and hepatology
2013;28 Suppl 1:125â€“31
</cite> [<a href="https://doi.org/10.1111/jgh.12021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3937070/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23855308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20gastroenterology%20and%20hepatology&amp;title=Forkhead%20box%20class%20O%20transcription%20factors%20in%20liver%20function%20and%20disease&amp;author=I%20Tikhanovich&amp;author=J%20Cox&amp;author=SA%20Weinman&amp;volume=28%20Suppl%201&amp;publication_year=2013&amp;pages=125-31&amp;pmid=23855308&amp;doi=10.1111/jgh.12021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Bouchard C, Lee S, Paulus-Hock V, Loddenkemper C, Eilers M, Schmitt CA. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. Genes Dev
2007;21:2775â€“87
</cite> [<a href="https://doi.org/10.1101/gad.453107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2045131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17974917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Dev&amp;title=FoxO%20transcription%20factors%20suppress%20Myc-driven%20lymphomagenesis%20via%20direct%20activation%20of%20Arf&amp;author=C%20Bouchard&amp;author=S%20Lee&amp;author=V%20Paulus-Hock&amp;author=C%20Loddenkemper&amp;author=M%20Eilers&amp;volume=21&amp;publication_year=2007&amp;pages=2775-87&amp;pmid=17974917&amp;doi=10.1101/gad.453107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Wang C, Cigliano A, Jiang L, Li X, Fan B, Pilo MG, et al. 
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Hepatology (Baltimore, Md)
2015;61:200â€“13</cite> [<a href="https://doi.org/10.1002/hep.27396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4280310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25145583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology%20(Baltimore,%20Md)&amp;title=4EBP1/eIF4E%20and%20p70S6K/RPS6%20axes%20play%20critical%20and%20distinct%20roles%20in%20hepatocarcinogenesis%20driven%20by%20AKT%20and%20N-Ras%20proto-oncogenes%20in%20mice&amp;author=C%20Wang&amp;author=A%20Cigliano&amp;author=L%20Jiang&amp;author=X%20Li&amp;author=B%20Fan&amp;volume=61&amp;publication_year=2015&amp;pages=200-13&amp;pmid=25145583&amp;doi=10.1002/hep.27396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J
2008;412:179â€“90
</cite> [<a href="https://doi.org/10.1042/BJ20080281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2735030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18466115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=The%20TSC1-TSC2%20complex:%20a%20molecular%20switchboard%20controlling%20cell%20growth&amp;author=J%20Huang&amp;author=BD%20Manning&amp;volume=412&amp;publication_year=2008&amp;pages=179-90&amp;pmid=18466115&amp;doi=10.1042/BJ20080281&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Cotler SJ, Hay N, Xie H, Chen ML, Xu PZ, Layden TJ, et al. 
Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease. Dig Dis Sci
2008;53:844â€“9
</cite> [<a href="https://doi.org/10.1007/s10620-007-9934-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17763954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dig%20Dis%20Sci&amp;title=Immunohistochemical%20expression%20of%20components%20of%20the%20Akt-mTORC1%20pathway%20is%20associated%20with%20hepatocellular%20carcinoma%20in%20patients%20with%20chronic%20liver%20disease&amp;author=SJ%20Cotler&amp;author=N%20Hay&amp;author=H%20Xie&amp;author=ML%20Chen&amp;author=PZ%20Xu&amp;volume=53&amp;publication_year=2008&amp;pages=844-9&amp;pmid=17763954&amp;doi=10.1007/s10620-007-9934-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Gusarova GA, Wang IC, Major ML, Kalinichenko VV, Ackerson T, Petrovic V, et al. 
A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest
2007;117:99â€“111
</cite> [<a href="https://doi.org/10.1172/JCI27527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1697798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17173139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Invest&amp;title=A%20cell-penetrating%20ARF%20peptide%20inhibitor%20of%20FoxM1%20in%20mouse%20hepatocellular%20carcinoma%20treatment&amp;author=GA%20Gusarova&amp;author=IC%20Wang&amp;author=ML%20Major&amp;author=VV%20Kalinichenko&amp;author=T%20Ackerson&amp;volume=117&amp;publication_year=2007&amp;pages=99-111&amp;pmid=17173139&amp;doi=10.1172/JCI27527&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Pauta M, Rotllan N, FernÃ¡ndez-Hernando A, Langhi C, Ribera J, Lu M, et al. 
Akt-mediated foxo1 inhibition is required for liver regeneration. Hepatology (Baltimore, Md)
2016;63:1660â€“74</cite> [<a href="https://doi.org/10.1002/hep.28286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5177729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26473496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology%20(Baltimore,%20Md)&amp;title=Akt-mediated%20foxo1%20inhibition%20is%20required%20for%20liver%20regeneration&amp;author=M%20Pauta&amp;author=N%20Rotllan&amp;author=A%20Fern%C3%A1ndez-Hernando&amp;author=C%20Langhi&amp;author=J%20Ribera&amp;volume=63&amp;publication_year=2016&amp;pages=1660-74&amp;pmid=26473496&amp;doi=10.1002/hep.28286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. 
YAP/TAZ incorporation in the Î²-catenin destruction complex orchestrates the Wnt response. Cell
2014;158:157â€“70
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.06.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24976009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=YAP/TAZ%20incorporation%20in%20the%20%CE%B2-catenin%20destruction%20complex%20orchestrates%20the%20Wnt%20response&amp;author=L%20Azzolin&amp;author=T%20Panciera&amp;author=S%20Soligo&amp;author=E%20Enzo&amp;author=S%20Bicciato&amp;volume=158&amp;publication_year=2014&amp;pages=157-70&amp;pmid=24976009&amp;doi=10.1016/j.cell.2014.06.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Eisinger-Mathason TS, Mucaj V, Biju KM, Nakazawa MS, Gohil M, Cash TP, et al. 
Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis. Proc Natl Acad Sci U S A
2015;112:E3402â€“11
</cite> [<a href="https://doi.org/10.1073/pnas.1420005112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4491775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26080399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Deregulation%20of%20the%20Hippo%20pathway%20in%20soft-tissue%20sarcoma%20promotes%20FOXM1%20expression%20and%20tumorigenesis&amp;author=TS%20Eisinger-Mathason&amp;author=V%20Mucaj&amp;author=KM%20Biju&amp;author=MS%20Nakazawa&amp;author=M%20Gohil&amp;volume=112&amp;publication_year=2015&amp;pages=E3402-11&amp;pmid=26080399&amp;doi=10.1073/pnas.1420005112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Fan Q, Cai Q, Xu Y. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. Oncotarget
2015;6:27688â€“99
</cite> [<a href="https://doi.org/10.18632/oncotarget.4280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4695018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26299613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=FOXM1%20is%20a%20downstream%20target%20of%20LPA%20and%20YAP%20oncogenic%20signaling%20pathways%20in%20high%20grade%20serous%20ovarian%20cancer&amp;author=Q%20Fan&amp;author=Q%20Cai&amp;author=Y%20Xu&amp;volume=6&amp;publication_year=2015&amp;pages=27688-99&amp;pmid=26299613&amp;doi=10.18632/oncotarget.4280&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>1</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-1.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-1.pdf</a><sup> (184.5KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>2</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-2.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-2.pdf</a><sup> (664.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><span>3</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-3.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-3.pdf</a><sup> (4.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><span>4</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-4.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-4.pdf</a><sup> (798.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p"><span>5</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-5.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-5.pdf</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p"><span>6</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-6.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-6.pdf</a><sup> (361KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p"><span>7</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-7.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-7.pdf</a><sup> (937.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p"><span>8</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-8.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-8.pdf</a><sup> (1.1MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="caption p"><span>9</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-9.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-9.pdf</a><sup> (1MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material10_reqid_"><div class="caption p"><span>10</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-10.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-10.pdf</a><sup> (215.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material11_reqid_"><div class="caption p"><span>11</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-11.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-11.pdf</a><sup> (109KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material12_reqid_"><div class="caption p"><span>12</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-12.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-12.pdf</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material13_reqid_"><div class="caption p"><span>13</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-13.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-13.pdf</a><sup> (716.1KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material14_reqid_"><div class="caption p"><span>14</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-14.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-14.pdf</a><sup> (951KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material15_reqid_"><div class="caption p"><span>15</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-15.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-15.pdf</a><sup> (976.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material16_reqid_"><div class="caption p"><span>16</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-16.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-16.pdf</a><sup> (70.4KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material17_reqid_"><div class="caption p"><span>17</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-17.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-17.pdf</a><sup> (105.8KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material18_reqid_"><div class="caption p"><span>18</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-18.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-18.pdf</a><sup> (104KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material19_reqid_"><div class="caption p"><span>19</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-19.pdf" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-19.pdf</a><sup> (206.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material20_reqid_"><div class="caption p"><span>20</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-20.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-20.docx</a><sup> (35.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material21_reqid_"><div class="caption p"><span>21</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-21.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-21.docx</a><sup> (54.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material22_reqid_"><div class="caption p"><span>22</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-22.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-22.docx</a><sup> (35.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material23_reqid_"><div class="caption p"><span>23</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-23.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-23.docx</a><sup> (33.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material24_reqid_"><div class="caption p"><span>24</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-24.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-24.docx</a><sup> (34.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material25_reqid_"><div class="caption p"><span>25</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-25.docx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-25.docx</a><sup> (37.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material26_reqid_"><div class="caption p"><span>26</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-26.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-26.xlsx</a><sup> (678.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material27_reqid_"><div class="caption p"><span>27</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-27.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-27.xlsx</a><sup> (70.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material28_reqid_"><div class="caption p"><span>28</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-28.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-28.xlsx</a><sup> (48.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material29_reqid_"><div class="caption p"><span>29</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-29.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-29.xlsx</a><sup> (201.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material30_reqid_"><div class="caption p"><span>30</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-30.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-30.xlsx</a><sup> (188.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material31_reqid_"><div class="caption p"><span>31</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-31.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-31.xlsx</a><sup> (148.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material32_reqid_"><div class="caption p"><span>32</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12500318/bin/NIHMS2112487-supplement-32.xlsx" data-ga-action="click_feat_suppl" class="usa-link">NIHMS2112487-supplement-32.xlsx</a><sup> (37.4KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All other raw data generated in this study are available upon request from the corresponding author. The RNA-seq data for this study were deposited in the Gene Expression Omnibus (GEO) database (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301912" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE301912</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301906" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE301906</a>). The analyzed data in <a href="#F6" class="usa-link">Fig. 6A</a> and <a href="#F6" class="usa-link">6B</a> were obtained from the TCGA database via the UALCAN portal [<a href="https://ualcan.path.uab.edu/cgibin/TCGAExResultNew2.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgibin/TCGAExResultNew2.pl?genenam=FOXM1&amp;ctype=LIHC</a>;<a href="https://ualcan.path.uab.edu/cgi-bin/TCGA-survival1.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgi-bin/TCGA-survival1.pl?genenam=FOXM1&amp;ctype=LIHC</a>]. The analyzed data in <a href="#SD10" class="usa-link">Supplementary Fig. S10</a> were obtained from the TCGA database [<a href="https://www.cbioportal.org/results/download?cancer_study_list=lihc_tcga_pan_can_atlas_2018&amp;Z_SCORE_THRESHOLD=2.0&amp;RPPA_SCORE_THRESHOLD=2.0&amp;profileFilter=mutations%2Cstructural_variants%2Cgistic&amp;case_set_id=lihc_tcga_pan_can_atlas_2018_cnaseq&amp;gene_list=FOXM1&amp;geneset_list=&amp;tab_index=tab_visualize&amp;Action=Submit" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cbioportal.org/results/download?cancer_study_list=lihc_tcga_pan_can_atlas_2018&amp;Z_SCORE_THRESHOLD=2.0&amp;RPPA_SCORE_THRESHOLD=2.0&amp;profileFilter=mutations%2Cstructural_variants%2Cgistic&amp;case_set_id=lihc_tcga_pan_can_atlas_2018_cnaseq&amp;gene_list=FOXM1&amp;geneset_list=%20&amp;tab_index=tab_visualize&amp;Action=Submit</a> ]. The analyzed data in <a href="#SD11" class="usa-link">Supplementary Fig. S11</a> were extracted from UALCAN [<a href="https://ualcan.path.uab.edu/cgi-bin/ualcan-depmap-res.pl?genenam=FOXM1&amp;ctype=LIHC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ualcan.path.uab.edu/cgi-bin/ualcan-depmap-res.pl?genenam=FOXM1&amp;ctype=LIHC</a>]. The analyzed data in <a href="#F8" class="usa-link">Fig. 8E</a> and <a href="#SD16" class="usa-link">Supplementary Fig. S16</a>â€“<a href="#SD18" class="usa-link">18</a> were obtained from the Cancer Proteome Atlas (TCPA) database [<a href="https://tcpa.drbioright.org/rppa500/correlation_analysis.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tcpa.drbioright.org/rppa500/correlation_analysis.html</a>].</p>
<figure class="fig xbox font-sm" id="db_da_fig6_reqid_"><h3 class="obj_head">Figure 6. FOXM1 is a target regulated downstream of AKT/GSK3Î±/Î² cascade in HCC.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/88a5f200ba73/nihms-2112487-f0006.jpg" loading="lazy" height="2100" width="1521" alt="Figure 6."></p>
<div class="p text-right font-secondary"><a href="figure/db_da_fig6_reqid_/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A,</strong> The expression level of <em>FOXM1</em> in human HCC samples from TCGA. Normal: n=50; Primary tumor: n=371. <strong>B,</strong> The effect of <em>FOXM1</em> expression level on LIHC patient survival. <strong>C,</strong> RNA-seq analysis of the expression level of <em>Foxm1</em> in normal liver and liver tumor tissues of <em>Tsc2</em><sup>âˆ’/âˆ’</sup><em>/NRas</em>, <em>sgGSK3Î±/Î²/NRas</em> and <em>Akt/NRas</em>. n=4 per group. Statistical significance was determined by one-way ANOVA test. <strong>D,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>sgGFP</em> or <em>sgFoxm1</em> plasmid together with <em>Akt</em> and <em>NRas</em> plasmids. <strong>E,</strong> The survival curves of <em>Akt/NRas/sgGFP</em> (n=6) and <em>Akt/NRas/sgFoxm1</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>F,</strong> Representative gross images from <em>Akt/NRas/sgGFP</em> (7.6w.p.i.) and <em>Akt/NRas/sgFoxm1</em> (7.6w.p.i.) mice. 6 biological replicates were performed with similar results. <strong>G,</strong> Study design. <em>FVB/N</em> mice were hydrodynamically injected with either <em>sgGFP</em> or <em>sgFoxm1</em> plasmid together with <em>sgGSK3Î±/Î²</em> and <em>NRas</em> plasmids. <strong>H,</strong> The survival curves of <em>sgGSK3Î±/Î²/NRas/sgGFP</em> (n=6) and <em>sgGSK3Î±/Î²/NRas/sgFoxm1</em> (n=6) mice. Statistical significance was determined by log-rank tests. <strong>I,</strong> Representative gross images from <em>sgGSK3Î±/Î²/NRas/sgGFP</em> (14.1w.p.i.) mice (n=5) and <em>sgGSK3Î±/Î²/NRas/sgFoxm1</em> (14.1w.p.i. &amp; 24w.p.i.) mice (n=6). Data are presented as mean Â± SD; ** indicates p &lt; 0.01. Abbreviations: w.p.i., weeks post-injection.</p></figcaption></figure><figure class="fig xbox font-sm" id="db_da_fig8_reqid_"><h3 class="obj_head">Figure 8. Activated AKT is associated with the inactivation of GSK3Î±/Î² in human HCC patients.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea76/12500318/697295a26296/nihms-2112487-f0008.jpg" loading="lazy" height="2100" width="1523" alt="Figure 8."></p>
<div class="p text-right font-secondary"><a href="figure/db_da_fig8_reqid_/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A,</strong> Activation or inhibition status of AKT, GSK3Î±, and GSK3Î² in human HCCs (n=108) as determined by IHC staining. <strong>B,</strong> Correlation between p-AKT<sup>Ser473</sup> and p-GSK3Î±<sup>Ser21</sup>/p-GSK3Î²<sup>Ser9</sup> in human HCC samples in (<strong>A</strong>). <strong>C,</strong> Representative immunohistochemistry patterns of p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins in human hepatocellular carcinoma (HCC; n=108). The upper panels show a non-tumorous surrounding liver tissue (ST) displaying weak or absent immunoreactivity for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> in non-neoplastic hepatocytes. In the middle panels, a human HCC (denominated HCC1) exhibits strong and concomitant enhanced immunoreactivity for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins. The lowest panels depict a second tumor (HCC2), characterized by robust immunolabeling for p-AKT<sup>Ser473</sup>, p-GSK3Î±<sup>Ser21</sup>, and p-GSK3Î²<sup>Ser9</sup> proteins. Abbreviation: H&amp;E, hematoxylin and eosin staining. Original magnifications: 200Ã— in all panels. Scale bar: 100 Î¼m in all panels. <strong>D,</strong> Comparison of p-GSK3Î±<sup>Ser21</sup> and p-GSK3Î²<sup>Ser9</sup> positive (both or either) and both negative immunoreactivity frequency between p-AKT<sup>Ser473</sup>-positive (n=43) and p-AKT<sup>Ser473</sup>-negative (n=65) human HCC samples in (<strong>A</strong>). <strong>E,</strong> The correlation analysis between p-GSK3Î²<sup>Ser9</sup> and FOXM1 in human HCC samples (n=184) from the Cancer Proteome Atlas (TCPA) database.</p></figcaption></figure></section></section></section></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1158/0008-5472.CAN-25-1615"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/nihms-2112487.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.8Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12500318/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12500318/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12500318%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12500318/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12500318/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12500318/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40939191/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12500318/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40939191/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12500318/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12500318/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="C7jmPJr30Jwu2M0XFGT2eExN78IYrNpvoNTvFuWwqYJ8EQjaFyN1GMuIjK1SVcV3">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
